PRKD1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A6ND36 | S356 | SIGNOR|PSP | FAM83G PAWS1 | PAGTVAKKLVNPKYALVKAKsVDEIAKIssEKQEAKKPLGL |
| O00206 | S790 | EPSD|PSP | TLR4 | VLQKVEKTLLRQQVELYRLLsRNTYLEWEDSVLGRHIFWRR |
| O00429 | S637 | EPSD|PSP | DNM1L DLP1 DRP1 | PQKGHAVNLLDVPVPVARKLsAREQRDCEVIERLIKSYFLI |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14558 | S16 | EPSD|PSP | HSPB6 | _____MEIPVPVQPSWLRRAsAPLPGLSAPGRLFDQRFGEG |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O15143 | S310 | Sugiyama | ARPC1B ARC41 | QSSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVs |
| O15273 | S157 | EPSD|PSP | TCAP | TKQLPPVVPVSKPGALRRSLsRSMsQEAQRG__________ |
| O15273 | S161 | EPSD|PSP | TCAP | PPVVPVSKPGALRRSLsRSMsQEAQRG______________ |
| O15355 | T528 | Sugiyama | PPM1G PPM1C | RNTAELQPEsGKRKLEEVLstEGAEENGNsDKKKKAKRD__ |
| O15460 | T532 | Sugiyama | P4HA2 UNQ290/PRO330 | WVSNKWFHERGQEFLRPCGstEVD_________________ |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60331 | S448 | PSP | PIP5K1C KIAA0589 | PSFYAERFFKFMSNTVFRKNsSLKSsPSKKGRGGALLAVKP |
| O60343 | S486 | Sugiyama | TBC1D4 AS160 KIAA0603 | ERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVS |
| O60602 | S805 | GPS6|SIGNOR|EPSD|PSP | TLR5 TIL3 | SALIMVVVGSLSQyQLMKHQsIRGFVQKQQYLRWPEDLQDV |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O75340 | S120 | Sugiyama | PDCD6 ALG2 | RTYDRDNsGMIDKNELKQALsGFGYRLSDQFHDILIRKFDR |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75628 | S18 | SIGNOR|EPSD|PSP | REM1 GES REM | ___MTLNTEQEAKTPLHRRAsTPLPLSPRGHQPGRLSTVPS |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O94806 | S391 | Sugiyama | PRKD3 EPK2 PRKCN | FFLDPsDLDVERDEEAVKtIsPstsNNIPLMRVVQSIKHTK |
| O94806 | S395 | Sugiyama | PRKD3 EPK2 PRKCN | PsDLDVERDEEAVKtIsPstsNNIPLMRVVQSIKHTKRKSS |
| O94806 | S735 | Sugiyama | PRKD3 EPK2 PRKCN | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNR |
| O94806 | T739 | Sugiyama | PRKD3 EPK2 PRKCN | CDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNRSLDM |
| O94806 | Y742 | Sugiyama | PRKD3 EPK2 PRKCN | GFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNRSLDMWSV |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95251 | T331 | SIGNOR|PSP | KAT7 HBO1 HBOa MYST2 | RRAQARASEDLEKLRLQGQItEGSNMIKTIAFGRYELDTWY |
| O95251 | T97 | SIGNOR|PSP | KAT7 HBO1 HBOa MYST2 | VTRsQQQPtPVtPKKYPLRQtRssGsEtEQVVDFsDRETKN |
| O95292 | S158 | Sugiyama | VAPB UNQ484/PRO983 | NKIIstTAsKtEtPIVSKsLsssLDDtEVKKVMEECKRLQG |
| O95863 | S11 | SIGNOR|EPSD|PSP | SNAI1 SNAH | __________MPRSFLVRKPsDPNRKPNYSELQDSNPEFTF |
| O96013 | S181 | PSP | PAK4 KIAA1142 | KSSREGsGGPQESSRDKRPLsGPDVGtPQPAGLAsGAKLAA |
| O96013 | S474 | SIGNOR|PSP | PAK4 KIAA1142 | VKLSDFGFCAQVSKEVPRRKsLVGtPYWMAPELISRLPYGP |
| O96013 | S99 | EPSD|PSP | PAK4 KIAA1142 | DGALTLLLDEFENMSVTRsNsLRRDsPPPPARARQENGMPE |
| P00533 | T678 | GPS6 | EGFR ERBB ERBB1 HER1 | LVVALGIGLFMRRRHIVRKRtLRRLLQERELVEPLtPsGEA |
| P00533 | T693 | GPS6 | EGFR ERBB ERBB1 HER1 | IVRKRtLRRLLQERELVEPLtPsGEAPNQALLRILKETEFK |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P04075 | S354 | Sugiyama | ALDOA ALDA | ANsLACQGKytPsGQAGAAAsEsLFVsNHAy__________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | GPS6|ELM|EPSD|PSP|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | S83 | Sugiyama | HSPB1 HSP27 HSP28 | IEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVNH |
| P05412 | S63 | EPSD|PSP | JUN | ADPVGSLKPHLRAKNsDLLtsPDVGLLKLAsPELERLIIQS |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05549 | S258 | EPSD|PSP | TFAP2A AP2TF TFAP2 | LsPPECLNASLLGGVLRRAKsKNGGRSLREKLDKIGLNLPA |
| P05549 | S326 | EPSD|PSP | TFAP2A AP2TF TFAP2 | YVCETEFPAKAVAEFLNRQHsDPNEQVTRKNMLLATKQICK |
| P05997 | S1277 | Sugiyama | COL5A2 | APDDKNKTDPGVHATLKSLSsQIETMRSPDGSKKHPARTCD |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12277 | S164 | Sugiyama | CKB CKBB | PHCsRGERRAIEKLAVEALssLDGDLAGRyyALKsMtEAEQ |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15374 | S128 | Sugiyama | UCHL3 | KDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRVtH |
| P15880 | S249 | Sugiyama | RPS2 RPS4 | CtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEF |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P16220 | S119 | PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19174 | S1248 | SIGNOR|iPTMNet | PLCG1 PLC1 | LRERGsDASGQLFHGRAREGsFEsRyQQPFEDFRIsQEHLA |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19429 | S23 | GPS6 | TNNI3 TNNC1 | DGSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsA |
| P19429 | S24 | GPS6 | TNNI3 TNNC1 | GSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAs |
| P22059 | S240 | SIGNOR|EPSD|PSP | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23528 | S3 | SIGNOR|EPSD|PSP | CFL1 CFL | __________________MAsGVAVsDGVIKVFNDMKVRKs |
| P23528 | S41 | Sugiyama | CFL1 CFL | RKsstPEEVKKRKKAVLFCLsEDKKNIILEEGKEILVGDVG |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26599 | S131 | Sugiyama | PTBP1 PTB | VNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARAQAAL |
| P26641 | S25 | Sugiyama | EEF1G EF1G PRO1608 | TLyTyPENWRAFKALIAAQYsGAQVRVLsAPPHFHFGQtNR |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27986 | S154 | SIGNOR|PSP | PIK3R1 GRB1 | KLVEAIEKKGLECSTLyRtQssSNLAELRQLLDCDTPSVDL |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30559 | S261 | PSP | OXTR | AEAPEGAAAGDGGRVALARVsSVKLISKAKIRTVKMTFIIV |
| P31749 | S473 | EPSD|PSP | AKT1 PKB RAC | DQDDSMECVDSERRPHFPQFsysAsGtA_____________ |
| P31749 | T308 | EPSD|PSP | AKT1 PKB RAC | IKITDFGLCKEGIKDGAtMKtFCGtPEyLAPEVLEDNDyGR |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S363 | Sugiyama | HSPA4 APG2 HSPH2 | GATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAIL |
| P35222 | T112 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | QRVRAAMFPEtLDEGMQIPStQFDAAHPtNVQRLAEPSQML |
| P35222 | T120 | SIGNOR|EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | PEtLDEGMQIPStQFDAAHPtNVQRLAEPSQMLKHAVVNLI |
| P35236 | S246 | SIGNOR | PTPN7 | KECPEYTVRQLTIQYQEERRsVKHILFSAWPDHQTPESAGP |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35670 | S1121 | SIGNOR|PSP | ATP7B PWD WC1 WND | GIGCKVSNVEGILAHSERPLsAPASHLNEAGSLPAEKDAVP |
| P35670 | S1453 | SIGNOR|PSP | ATP7B PWD WC1 WND | LTSDKPSRHSAAADDDGDKWsLLLNGRDEEQYI________ |
| P35670 | S478 | SIGNOR|PSP | ATP7B PWD WC1 WND | EVAPHTGRLPANHAPDILAKsPQsTRAVAPQKCFLQIKGMT |
| P35670 | S481 | SIGNOR|PSP | ATP7B PWD WC1 WND | PHTGRLPANHAPDILAKsPQsTRAVAPQKCFLQIKGMTCAS |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40227 | S49 | Sugiyama | CCT6A CCT6 CCTZ | GLQDVLRTNLGPKGTMKMLVsGAGDIKLTKDGNVLLHEMQI |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46013 | S1689 | Sugiyama | MKI67 | DGKSMKAFMEsPKQILDsAAsLtGsKRQLRTPKGKsEVPED |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P47712 | S731 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | AMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA__ |
| P48426 | T376 | SIGNOR|EPSD|PSP | PIP4K2A PI5P4KA PIP5K2 PIP5K2A | AIIDILTHYDAKKKAAHAAKtVKHGAGAEISTVNPEQYSKR |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P50552 | S157 | EPSD|PSP | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50552 | S322 | EPSD|PSP | VASP | QSEsVRRPWEKNstTLPRMKssssVttsEtQPCtPsSSDyS |
| P53367 | S132 | SIGNOR|EPSD|PSP | ARFIP1 | ILADEIKNPAMEKLELVRKWsLNTYKCTRQIISEKLGRGSR |
| P53396 | S478 | Sugiyama | ACLY | EsRADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTK |
| P53999 | S10 | Sugiyama | SUB1 PC4 RPO2TC1 | ___________MPKSKELVsssssGsDsDsEVDKKLKRKKQ |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P57772 | S28 | Sugiyama | EEFSEC SELB | VNVGVLGHIDSGKTALARALsTTASTAAFDKQPQSRERGIT |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60468 | S49 | Sugiyama | SEC61B | STVRQRKNASCGTRSAGRtTsAGTGGMWRFYTEDSPGLKVG |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61221 | S591 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | NNYRPRINKLNsIKDVEQKKsGNyFFLDD____________ |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63010 | S258 | PSP | AP2B1 ADTB2 CLAPB1 | QSICERVTPRLSHANSAVVLsAVKVLMKFLELLPKDSDyyN |
| P63010 | Y277 | PSP | AP2B1 ADTB2 CLAPB1 | LsAVKVLMKFLELLPKDSDyyNMLLKKLAPPLVTLLSGEPE |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63151 | S113 | Sugiyama | PPP2R2A | EEKINKIRWLPQKNAAQFLLsTNDKTIKLWKISERDKRPEG |
| P63165 | S31 | Sugiyama | SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43 | EDLGDKKEGEYIKLKVIGQDssEIHFKVKMTTHLKKLKESY |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T261 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q04206 | S131 | Sugiyama | RELA NFKB3 | HSFQNLGIQCVKKRDLEQAIsQRIQtNNNPFQVPIEEQRGD |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q05639 | T261 | Sugiyama | EEF1A2 EEF1AL STN | PTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRPGMVVTFA |
| Q06124 | S140 | Sugiyama | PTPN11 PTP2C SHPTP2 | KEAEKLLTEKGKHGsFLVREsQsHPGDFVLSVRTGDDKGES |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q12809 | S284 | SIGNOR | KCNH2 ERG ERG1 HERG | SCSLARTRSRESCASVRRAssADDIEAMRAGVLPPPPRHAS |
| Q13563 | S801 | SIGNOR | PKD2 TRPP1 TRPP2 | DLEKEREDLDLDHssLPRPMssRSFPRSLDDsEEDDDEDSG |
| Q13573 | S182 | Sugiyama | SNW1 SKIIP SKIP | AMPVRAADKLAPAQyIRytPsQQGVAFNsGAKQRVIRMVEM |
| Q13596 | S229 | Sugiyama | SNX1 | PPPPEKSLIGMTKVKVGKEDsssAEFLEKRRAALERYLQRI |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q13671 | S292 | GPS6|SIGNOR|EPSD|PSP | RIN1 | GAVPSQTERLPPCQLLRREssVGYRVPAGSGPSLPPMPSLQ |
| Q13671 | S351 | GPS6|SIGNOR|ELM|EPSD|PSP | RIN1 | RGsPAtsPHLGRRRPLLRsMsAAFCsLLAPERQVGRAAAAL |
| Q13936 | S1981 | SIGNOR|EPSD|PSP | CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 | DIRQSPKRGFLRSASLGRRAsFHLECLKRQKDRGGDISQKT |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14247 | S298 | GPS6|SIGNOR|EPSD|PSP | CTTN EMS1 | ERQDsAAVGFDyKEKLAKHEsQQDySKGFGGKyGVQKDRMD |
| Q14247 | S348 | GPS6|SIGNOR|EPSD|PSP | CTTN EMS1 | tQVssAyQKTVPVEAVtsKtsNIRANFENLAKEKEQEDRRK |
| Q14257 | S37 | Sugiyama | RCN2 ERC55 | AAAAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKL |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14896 | S304 | EPSD|PSP | MYBPC3 | sDSHEDTGILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEI |
| Q15021 | S1333 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | APsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPNTQ |
| Q15139 | S205 | GPS6|SIGNOR|ELM|iPTMNet | PRKD1 PKD PKD1 PRKCM | HKRCAFKIPNNCSGVRRRRLsNVsLtGVSTIRtssAELsTs |
| Q15139 | S223 | Sugiyama | PRKD1 PKD PKD1 PRKCM | RLsNVsLtGVSTIRtssAELsTsAPDEPLLQKsPsEsFIGR |
| Q15139 | S225 | Sugiyama | PRKD1 PKD PKD1 PRKCM | sNVsLtGVSTIRtssAELsTsAPDEPLLQKsPsEsFIGREK |
| Q15139 | S237 | Sugiyama | PRKD1 PKD PKD1 PRKCM | tssAELsTsAPDEPLLQKsPsEsFIGREKRsNsQsyIGRPI |
| Q15139 | S239 | Sugiyama | PRKD1 PKD PKD1 PRKCM | sAELsTsAPDEPLLQKsPsEsFIGREKRsNsQsyIGRPIHL |
| Q15139 | S247 | Sugiyama | PRKD1 PKD PKD1 PRKCM | PDEPLLQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKV |
| Q15139 | S249 | Sugiyama | PRKD1 PKD PKD1 PRKCM | EPLLQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKVKV |
| Q15139 | S251 | Sugiyama | PRKD1 PKD PKD1 PRKCM | LLQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKVKVPH |
| Q15139 | S397 | Sugiyama | PRKD1 PKD PKD1 PRKCM | NDSGEMQDPDPDHEDANRtIsPstsNNIPLMRVVQsVKHTK |
| Q15139 | S401 | Sugiyama | PRKD1 PKD PKD1 PRKCM | EMQDPDPDHEDANRtIsPstsNNIPLMRVVQsVKHTKRKSs |
| Q15139 | S460 | Sugiyama | PRKD1 PKD PKD1 PRKCM | KRHYWRLDSKCItLFQNDTGsRYyKEIPLSEILsLEPVKTS |
| Q15139 | S68 | Sugiyama | PRKD1 PKD PKD1 PRKCM | GISFHLQIGLSREPVLLLQDsSGDYSLAHVREMACSIVDQK |
| Q15139 | S738 | GPS6|SIGNOR|iPTMNet|PSP | PRKD1 PKD PKD1 PRKCM | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNK |
| Q15139 | S742 | GPS6|SIGNOR|iPTMNet|EPSD|PSP|Sugiyama | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q15139 | S910 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PRKD1 PKD PKD1 PRKCM | SHSDTPETEETEMKALGERVsIL__________________ |
| Q15139 | T452 | Sugiyama | PRKD1 PKD PKD1 PRKCM | yTSKDTLRKRHYWRLDSKCItLFQNDTGsRYyKEIPLSEIL |
| Q15139 | T746 | Sugiyama | PRKD1 PKD PKD1 PRKCM | CDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNRSLDM |
| Q15139 | Y252 | Sugiyama | PRKD1 PKD PKD1 PRKCM | LQKsPsEsFIGREKRsNsQsyIGRPIHLDKILMSKVKVPHT |
| Q15139 | Y749 | Sugiyama | PRKD1 PKD PKD1 PRKCM | GFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNRSLDMWSV |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15276 | S407 | EPSD|PSP | RABEP1 RAB5EP RABPT5 RABPT5A | GDPFSKSDNDMFKDGLRRAQstDsLGtsGsLQSKALGYNYK |
| Q15459 | S690 | Sugiyama | SF3A1 SAP114 | VHPPPPMEDEPTSKKLKTEDsLMPEEEFLRRNKGPVSIKVQ |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16204 | S325 | Sugiyama | CCDC6 D10S170 TST1 | QRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGL |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5VT52 | S1068 | Sugiyama | RPRD2 KIAA0460 HSPC099 | SLTATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETL |
| Q5VTE0 | T261 | Sugiyama | EEF1A1P5 EEF1AL3 | PTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKPGMVVtFA |
| Q6FI81 | T250 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ASLRAASCGEGKKRKACKNCtCGLAEELEKEKSREQMSSQP |
| Q6PID6 | S19 | Sugiyama | TTC33 | __MASFGWKRKIGEKVSKVTsQQFEAEAADEKDVVDNDEGN |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZI7 | S400 | GPS6|EPSD|PSP | MARK2 EMK1 | sADLtNssAPsPsHKVQRsVsANPKQRRFsDQAAGPAIPTS |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86W56 | S286 | Sugiyama | PARG | VGSEDVGTGPKNDNKLTRQEsCLGNsPPFEKESEPEsPMDV |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBP7 | T228 | Sugiyama | PCSK9 NARC1 PSEC0052 | VPEEDGTRFHRQASKCDsHGtHLAGVVSGRDAGVAKGASMR |
| Q8NFH8 | S631 | Sugiyama | REPS2 POB1 | AIQTAIRKNKEANAVLARLNsELQQQLKEVHQERIALENQL |
| Q8NI08 | S441 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | ELSsQTGGGMHKKDTLKECLsLDPEERKKAESQINNSAVEM |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WUI4 | S155 | GPS6|SIGNOR|ELM|EPSD|PSP | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WUI4 | S181 | SIGNOR | HDAC7 HDAC7A | LRYKPKKSLERRKNPLLRKEsAPPSLRRRPAETLGDSSPSS |
| Q8WUI4 | S358 | SIGNOR|EPSD|PSP | HDAC7 HDAC7A | LMTTERLSGSGLHWPLSRtRsEPLPPSATAPPPPGPMQPRL |
| Q8WUI4 | S486 | SIGNOR|EPSD|PSP | HDAC7 HDAC7A | GDtVLLPLAQGGHRPLsRAQssPAAPAsLSAPEPASQARVL |
| Q8WYL5 | S402 | EPSD|PSP | SSH1 KIAA1298 SSH1L | AKRNHSKCLVHCKMGVSRSAsTVIAYAMKEFGWPLEKAYNY |
| Q8WYL5 | S937 | SIGNOR|EPSD|PSP | SSH1 KIAA1298 SSH1L | KTICYtPTSSSMSSNLTRsssSDSIHsVRGKPGLVKQRTQE |
| Q8WYL5 | S978 | SIGNOR|EPSD|PSP | SSH1 KIAA1298 SSH1L | IETRLRLAGLTVssPLKRSHsLAKLGsLtFstEDLsSEADP |
| Q8WYL5 | S99 | SIGNOR | SSH1 KIAA1298 SSH1L | QVMINLLRCEDRIKLAVRLEsAWADRVRYMVVVYSSGRQDT |
| Q92918 | S171 | EPSD|PSP | MAP4K1 HPK1 | VRLADFGISAQIGAtLARRLsFIGtPYWMAPEVAAVALKGG |
| Q92934 | S118 | SIGNOR|EPSD|PSP | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S75 | SIGNOR|EPSD|PSP | BAD BBC6 BCL2L8 | PTSSSHHGGAGAVEIRsRHssyPAGtEDDEGMGEEPsPFRG |
| Q92934 | S99 | SIGNOR|EPSD|PSP | BAD BBC6 BCL2L8 | GtEDDEGMGEEPsPFRGRsRsAPPNLWAAQRYGRELRRMsD |
| Q96A00 | T38 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | PPP1R14A CPI17 PPP1INL | SRARGPGGsPGGLQKRHARVtVKYDRRELQRRLDVEKWIDG |
| Q96D71 | S767 | Sugiyama | REPS1 | AIQAsIRRNKETNTVLARLNsELQQQLKDVLEERISLEVQL |
| Q96QB1 | S1244 | SIGNOR|EPSD|PSP | DLC1 ARHGAP7 KIAA1723 STARD12 | NLAVCLAPSLFHLNTLKRENsSPRVMQRKQSLGKPDQKDLN |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q99683 | T838 | EPSD|PSP | MAP3K5 ASK1 MAPKKK5 MEKK5 | LKISDFGtSKRLAGINPCTEtFTGtLQyMAPEIIDKGPRGY |
| Q99814 | T324 | iPTMNet | EPAS1 BHLHE73 HIF2A MOP2 PASD2 | SGQYRMLAKHGGYVWLETQGtVIYNPRNLQPQCIMCVNYVL |
| Q99832 | S59 | Sugiyama | CCT7 CCTH NIP7-1 | TLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTL |
| Q9BST9 | S448 | SIGNOR | RTKN RTKN1 | IMKIEtPAPRKPPQALAKQGsLyHEMAIEPLDDIAAVTDIL |
| Q9BY44 | S528 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | DLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKAIE |
| Q9GZY8 | S155 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | PPttPQNEEIRAVGRLKRERsMsENAVRQNGQLVRNDsLWH |
| Q9GZY8 | S172 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | RERsMsENAVRQNGQLVRNDsLWHRsDsAPRNKISRFQAPI |
| Q9GZY8 | S275 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | RGGsAAAtsNPHHDNVRYGIsNIDTTIEGTSDDLTVVDAAS |
| Q9H0K1 | S674 | Sugiyama | SIK2 KIAA0781 QIK SNF1LK2 | QQESVSTLPASVHPQLSPRQsLEtQYLQHRLQKPSLLSKAQ |
| Q9H6S3 | S693 | Sugiyama | EPS8L2 EPS8R2 PP13181 | EGVRVySQLTMQKAFLEKQQsGSELEELMNKFHSMNQRRGE |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | S316 | Sugiyama | SH2D4A PPP1R38 SH2A | NSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAG |
| Q9H9Q2 | S225 | Sugiyama | COPS7B CSN7B | TQQQVEAEVTNIKKTLKAtAsSsAQEMEQQLAERECPPHAE |
| Q9NPD3 | S77 | Sugiyama | EXOSC4 RRP41 SKI6 | EIRGsRARALPDRALVNCQYssATFstGERKRRPHGDRKSC |
| Q9NPD3 | S78 | Sugiyama | EXOSC4 RRP41 SKI6 | IRGsRARALPDRALVNCQYssATFstGERKRRPHGDRKSCE |
| Q9NRA0 | S419 | EPSD|PSP | SPHK2 SK2 | sELtLtPDPAPPMAHsPLHRsVsDLPLPLPQPALASPGSPE |
| Q9NRA0 | S421 | EPSD|PSP | SPHK2 SK2 | LtLtPDPAPPMAHsPLHRsVsDLPLPLPQPALASPGSPEPL |
| Q9NVR5 | S773 | Sugiyama | DNAAF2 C14orf104 KTU | EFIKEKSATCSNEEKDNLNEsVITEEKETDGDHLsSLLNKT |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9P258 | S44 | Sugiyama | RCC2 KIAA1470 TD60 | GPRKRGGPAGRKRERPERCssssGGGssGDEDGLELDGAPG |
| Q9P286 | S99 | PSP | PAK5 KIAA1264 PAK7 | ETSINGLLEDFDNISVTRSNsLRKESPPTPDQGASSHGPGH |
| Q9UBF8 | S294 | SIGNOR|EPSD|PSP | PI4KB PIK4CB | RsKsDAtAsISLSSNLKRTAsNPKVENEDEELSSSTESIDN |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9ULD2 | T1204 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRLs |
| Q9ULH0 | S918 | SIGNOR|iPTMNet | KIDINS220 ARMS KIAA1250 | LNRRDTYRRRQMQRTITRQMsFDLTKLLVTEDWFSDISPQT |
| Q9UNH7 | S343 | Sugiyama | SNX6 | ANKALDKARAKNKDVLQAETsQQLCCQKFEKISESAKQELI |
| Q9UPN3 | S2769 | Sugiyama | MACF1 ABP620 ACF7 KIAA0465 KIAA0754 KIAA1251 | EAIEKRLISPELANMIQIDSsEFSDHRAQIEKQEGIEVCAL |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQL6 | S259 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3E5 | S5 | SIGNOR|EPSD|PSP | PTRH2 BIT1 PTH2 CGI-147 | ________________MPSKsLVMEYLAHPSTLGLAVGVAC |
| Q9Y3E5 | S87 | SIGNOR|EPSD|PSP | PTRH2 BIT1 PTH2 CGI-147 | MILVVRNDLKMGKGKVAAQCsHAAVSAYKQIQRRNPEMLKQ |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y5P4 | S132 | SIGNOR|EPSD|PSP | CERT1 CERT COL4A3BP STARD11 | IEQHKTESGYGsEssLRRHGsMVsLVSGAsGYsAtstssFK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 2.382582e-08 | 7.623 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.385983e-08 | 7.622 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.994231e-07 | 6.399 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 9.454599e-07 | 6.024 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.488103e-06 | 5.457 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.861460e-06 | 5.104 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.415966e-05 | 4.849 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.326212e-05 | 4.633 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.534164e-05 | 4.452 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.175683e-05 | 4.286 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.823001e-05 | 4.235 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.644394e-05 | 4.178 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.968440e-05 | 4.157 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.297380e-04 | 3.887 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.754537e-04 | 3.756 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.767437e-04 | 3.753 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.302665e-04 | 3.638 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.681351e-04 | 3.434 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.765106e-04 | 3.322 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.771910e-04 | 3.321 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.659962e-04 | 3.332 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.195161e-04 | 3.284 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.361815e-04 | 3.271 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.437605e-04 | 3.265 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.950238e-04 | 3.002 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.266102e-03 | 2.898 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.467160e-03 | 2.834 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.078137e-03 | 2.682 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.205188e-03 | 2.657 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.341434e-03 | 2.631 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.436408e-03 | 2.613 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.436408e-03 | 2.613 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.691909e-03 | 2.570 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.823975e-03 | 2.549 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.873349e-03 | 2.542 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.604462e-03 | 2.337 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.482636e-03 | 2.348 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.623706e-03 | 2.335 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.075871e-03 | 2.294 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.079376e-03 | 2.294 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.051448e-03 | 2.218 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.051448e-03 | 2.218 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.051448e-03 | 2.218 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.261610e-03 | 2.203 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.952082e-03 | 2.158 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.244092e-03 | 2.140 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.012343e-03 | 2.154 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.319671e-03 | 2.136 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.775647e-03 | 2.109 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.153046e-03 | 2.089 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.975288e-03 | 2.047 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 9.623102e-03 | 2.017 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.042152e-02 | 1.982 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.078423e-02 | 1.967 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.286115e-02 | 1.891 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.280719e-02 | 1.893 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.308194e-02 | 1.883 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.343847e-02 | 1.872 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.429631e-02 | 1.845 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.491105e-02 | 1.826 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.505519e-02 | 1.822 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.576717e-02 | 1.802 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.636072e-02 | 1.786 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.585302e-02 | 1.800 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.718122e-02 | 1.765 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.645721e-02 | 1.784 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.717464e-02 | 1.765 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.658738e-02 | 1.780 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.725869e-02 | 1.763 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.740308e-02 | 1.759 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.763418e-02 | 1.754 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.866080e-02 | 1.729 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.955625e-02 | 1.709 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.109069e-02 | 1.676 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.014673e-02 | 1.696 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.107130e-02 | 1.676 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.040155e-02 | 1.690 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.109069e-02 | 1.676 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 2.217315e-02 | 1.654 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.669652e-02 | 1.574 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.669652e-02 | 1.574 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.669652e-02 | 1.574 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.669652e-02 | 1.574 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.698976e-02 | 1.569 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.548381e-02 | 1.594 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.451827e-02 | 1.611 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.451827e-02 | 1.611 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.606405e-02 | 1.584 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.511267e-02 | 1.600 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.812073e-02 | 1.551 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.832048e-02 | 1.548 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.832048e-02 | 1.548 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.871722e-02 | 1.542 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.875086e-02 | 1.541 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.969583e-02 | 1.527 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.210902e-02 | 1.493 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.210902e-02 | 1.493 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.210902e-02 | 1.493 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.107454e-02 | 1.508 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.432473e-02 | 1.464 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.432473e-02 | 1.464 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.315806e-02 | 1.479 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.481476e-02 | 1.458 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.481476e-02 | 1.458 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.481476e-02 | 1.458 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.481476e-02 | 1.458 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.432473e-02 | 1.464 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.481476e-02 | 1.458 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.432473e-02 | 1.464 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.517734e-02 | 1.454 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.708678e-02 | 1.431 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.753015e-02 | 1.426 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.517734e-02 | 1.454 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.517734e-02 | 1.454 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.517734e-02 | 1.454 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.860235e-02 | 1.413 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.933044e-02 | 1.405 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.952999e-02 | 1.403 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.296381e-02 | 1.367 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.317619e-02 | 1.365 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.317619e-02 | 1.365 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.317619e-02 | 1.365 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.317619e-02 | 1.365 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.317619e-02 | 1.365 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.023882e-02 | 1.395 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.061739e-02 | 1.391 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.296381e-02 | 1.367 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.296381e-02 | 1.367 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.381741e-02 | 1.358 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.381741e-02 | 1.358 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.381741e-02 | 1.358 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.510446e-02 | 1.346 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.510446e-02 | 1.346 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 4.518964e-02 | 1.345 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 4.973181e-02 | 1.303 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.013654e-02 | 1.300 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.809816e-02 | 1.318 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.973181e-02 | 1.303 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.023817e-02 | 1.299 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.131531e-02 | 1.290 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.131531e-02 | 1.290 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.131531e-02 | 1.290 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.136542e-02 | 1.289 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.136542e-02 | 1.289 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 5.223727e-02 | 1.282 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.231697e-02 | 1.281 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.563640e-02 | 1.255 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.327736e-02 | 1.273 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.327736e-02 | 1.273 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.408330e-02 | 1.267 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 5.794508e-02 | 1.237 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.327736e-02 | 1.273 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 5.794508e-02 | 1.237 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.923274e-02 | 1.227 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.931200e-02 | 1.227 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.931200e-02 | 1.227 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.934014e-02 | 1.227 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.975952e-02 | 1.224 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.108749e-02 | 1.214 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.237186e-02 | 1.205 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.114091e-01 | 0.953 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.114091e-01 | 0.953 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 8.195056e-02 | 1.086 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 8.195056e-02 | 1.086 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 8.195056e-02 | 1.086 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 8.195056e-02 | 1.086 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 8.195056e-02 | 1.086 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.104120e-01 | 0.677 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.104120e-01 | 0.677 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.104120e-01 | 0.677 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.104120e-01 | 0.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.104120e-01 | 0.677 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.104120e-01 | 0.677 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.104120e-01 | 0.677 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.104120e-01 | 0.677 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.104120e-01 | 0.677 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.104120e-01 | 0.677 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.104120e-01 | 0.677 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.104120e-01 | 0.677 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 7.040806e-02 | 1.152 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.220191e-02 | 1.035 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.220191e-02 | 1.035 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.588116e-01 | 0.799 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.588116e-01 | 0.799 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.588116e-01 | 0.799 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.588116e-01 | 0.799 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.588116e-01 | 0.799 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.588116e-01 | 0.799 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.588116e-01 | 0.799 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 2.983895e-01 | 0.525 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.983895e-01 | 0.525 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.983895e-01 | 0.525 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.983895e-01 | 0.525 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.983895e-01 | 0.525 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.983895e-01 | 0.525 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.983895e-01 | 0.525 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.983895e-01 | 0.525 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.983895e-01 | 0.525 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.983895e-01 | 0.525 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 2.983895e-01 | 0.525 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.983895e-01 | 0.525 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.983895e-01 | 0.525 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.983895e-01 | 0.525 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.983895e-01 | 0.525 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.983895e-01 | 0.525 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.009873e-02 | 1.154 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.163958e-01 | 0.934 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.163958e-01 | 0.934 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.628908e-02 | 1.064 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.628908e-02 | 1.064 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.008593e-01 | 0.697 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.008593e-01 | 0.697 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.008593e-01 | 0.697 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.008593e-01 | 0.697 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.008593e-01 | 0.697 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.008593e-01 | 0.697 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.234709e-01 | 0.908 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.234709e-01 | 0.908 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.706639e-01 | 0.768 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.706639e-01 | 0.768 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.439827e-01 | 0.613 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.439827e-01 | 0.613 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.765690e-01 | 0.424 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.765690e-01 | 0.424 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.765690e-01 | 0.424 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.765690e-01 | 0.424 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.765690e-01 | 0.424 | 0 | 0 |
| Defective visual phototransduction due to STRA6 loss of function | R-HSA-9918449 | 3.765690e-01 | 0.424 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.000656e-01 | 0.699 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 2.874208e-01 | 0.541 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 2.874208e-01 | 0.541 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.874208e-01 | 0.541 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.394402e-01 | 0.856 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.893139e-01 | 0.723 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.893139e-01 | 0.723 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.767454e-01 | 0.753 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.767454e-01 | 0.753 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.617900e-01 | 0.582 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.617900e-01 | 0.582 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.305684e-01 | 0.481 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.305684e-01 | 0.481 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.305684e-01 | 0.481 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.460412e-01 | 0.351 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.460412e-01 | 0.351 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.460412e-01 | 0.351 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 4.460412e-01 | 0.351 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.460412e-01 | 0.351 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.460412e-01 | 0.351 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.460412e-01 | 0.351 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.460412e-01 | 0.351 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.171982e-01 | 0.931 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.935211e-01 | 0.532 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.935211e-01 | 0.532 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.935211e-01 | 0.532 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.935211e-01 | 0.532 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.373892e-02 | 1.077 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.989327e-01 | 0.701 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.989327e-01 | 0.701 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.989327e-01 | 0.701 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.636171e-01 | 0.579 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.729513e-01 | 0.428 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.729513e-01 | 0.428 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.729513e-01 | 0.428 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.729513e-01 | 0.428 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.729513e-01 | 0.428 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.729513e-01 | 0.428 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.729513e-01 | 0.428 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.729513e-01 | 0.428 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.310636e-02 | 1.136 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.132988e-01 | 0.946 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.254762e-01 | 0.487 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.822155e-02 | 1.008 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.136983e-02 | 1.039 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.895342e-01 | 0.538 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.604379e-01 | 0.584 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.359979e-01 | 0.627 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.359979e-01 | 0.627 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.804247e-01 | 0.744 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.804247e-01 | 0.744 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.116511e-01 | 0.674 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.827006e-01 | 0.549 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.827006e-01 | 0.549 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.157756e-01 | 0.501 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.574205e-01 | 0.447 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 3.574205e-01 | 0.447 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.142044e-01 | 0.383 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.142044e-01 | 0.383 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.142044e-01 | 0.383 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.142044e-01 | 0.383 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 4.142044e-01 | 0.383 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.077753e-01 | 0.294 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.077753e-01 | 0.294 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 5.077753e-01 | 0.294 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.077753e-01 | 0.294 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 5.077753e-01 | 0.294 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.077753e-01 | 0.294 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.183538e-01 | 0.927 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.492635e-01 | 0.603 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.749559e-01 | 0.561 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.868657e-01 | 0.728 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.051441e-01 | 0.978 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.051441e-01 | 0.978 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.558957e-01 | 0.807 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.422012e-01 | 0.466 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.422012e-01 | 0.466 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.422012e-01 | 0.466 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.422012e-01 | 0.466 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.669924e-01 | 0.574 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.498440e-01 | 0.824 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.891455e-01 | 0.410 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.281643e-01 | 0.484 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.152747e-01 | 0.501 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.540535e-01 | 0.343 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.540535e-01 | 0.343 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.511815e-01 | 0.454 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.511815e-01 | 0.454 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.949396e-01 | 0.710 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.846310e-01 | 0.734 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.820787e-01 | 0.550 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.820787e-01 | 0.550 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.204685e-01 | 0.376 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.204685e-01 | 0.376 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 4.204685e-01 | 0.376 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.219525e-01 | 0.492 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.093686e-01 | 0.510 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.093686e-01 | 0.510 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.093686e-01 | 0.510 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.977974e-01 | 0.526 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.870729e-01 | 0.542 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.742721e-01 | 0.427 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.742721e-01 | 0.427 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.742721e-01 | 0.427 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.564262e-01 | 0.448 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.564262e-01 | 0.448 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.564262e-01 | 0.448 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.406982e-01 | 0.468 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.137241e-01 | 0.503 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.922992e-01 | 0.308 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.626328e-01 | 0.250 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.626328e-01 | 0.250 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.626328e-01 | 0.250 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.626328e-01 | 0.250 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.626328e-01 | 0.250 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.626328e-01 | 0.250 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.626328e-01 | 0.250 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.626328e-01 | 0.250 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.626328e-01 | 0.250 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.626328e-01 | 0.250 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.626328e-01 | 0.250 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.460757e-01 | 0.461 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.983416e-01 | 0.525 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.790041e-01 | 0.421 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.482333e-01 | 0.458 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.628581e-01 | 0.440 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.813021e-01 | 0.318 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.358062e-01 | 0.474 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.613099e-01 | 0.442 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.728197e-01 | 0.325 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.288042e-01 | 0.277 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.288042e-01 | 0.277 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.288042e-01 | 0.277 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.288042e-01 | 0.277 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.597178e-01 | 0.338 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.105670e-01 | 0.292 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.105670e-01 | 0.292 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.251134e-01 | 0.371 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.979274e-01 | 0.303 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.800055e-01 | 0.319 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.800055e-01 | 0.319 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.800055e-01 | 0.319 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.100953e-01 | 0.292 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.100953e-01 | 0.292 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.100953e-01 | 0.292 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.389357e-01 | 0.268 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.389357e-01 | 0.268 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.634814e-01 | 0.249 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.634814e-01 | 0.249 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.113795e-01 | 0.214 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.113795e-01 | 0.214 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.113795e-01 | 0.214 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.113795e-01 | 0.214 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.113795e-01 | 0.214 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.113795e-01 | 0.214 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.113795e-01 | 0.214 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.113795e-01 | 0.214 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.113795e-01 | 0.214 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.113795e-01 | 0.214 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.113795e-01 | 0.214 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.113795e-01 | 0.214 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.113795e-01 | 0.214 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.781261e-01 | 0.320 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.316800e-01 | 0.274 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.316800e-01 | 0.274 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.777433e-01 | 0.321 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.415804e-01 | 0.266 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.698385e-01 | 0.244 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.962849e-01 | 0.225 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.962849e-01 | 0.225 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 5.962849e-01 | 0.225 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 5.962849e-01 | 0.225 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.962849e-01 | 0.225 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.634506e-01 | 0.249 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.924964e-01 | 0.227 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.185907e-01 | 0.209 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.169007e-01 | 0.210 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.144321e-01 | 0.212 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.180248e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.272015e-01 | 0.203 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.272015e-01 | 0.203 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.272015e-01 | 0.203 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.886148e-02 | 1.162 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.584028e-01 | 0.253 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 8.802370e-02 | 1.055 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.552734e-01 | 0.593 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.431847e-01 | 0.353 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.588698e-01 | 0.587 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 5.198321e-01 | 0.284 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.505546e-02 | 1.070 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.881167e-01 | 0.311 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.186174e-01 | 0.378 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.962849e-01 | 0.225 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.680993e-01 | 0.246 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.167508e-01 | 0.664 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.391683e-01 | 0.357 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.841980e-01 | 0.315 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.133517e-01 | 0.671 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.234709e-01 | 0.908 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.538774e-02 | 1.069 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.989327e-01 | 0.701 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.281643e-01 | 0.484 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.927122e-01 | 0.227 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.924964e-01 | 0.227 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.136727e-01 | 0.944 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.149877e-01 | 0.668 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.238511e-01 | 0.650 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.727303e-01 | 0.429 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.966373e-01 | 0.706 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.288042e-01 | 0.277 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.234988e-02 | 1.084 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.270891e-01 | 0.644 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.422012e-01 | 0.466 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.891455e-01 | 0.410 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.714805e-01 | 0.766 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.724417e-02 | 1.112 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.306886e-02 | 1.136 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 1.642745e-01 | 0.784 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.254762e-01 | 0.487 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.357787e-01 | 0.474 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.936505e-01 | 0.226 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.893139e-01 | 0.723 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.381718e-01 | 0.623 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.827006e-01 | 0.549 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.574205e-01 | 0.447 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.142044e-01 | 0.383 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.152747e-01 | 0.501 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.152747e-01 | 0.501 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.846310e-01 | 0.734 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.056459e-01 | 0.687 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.595751e-01 | 0.444 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.788829e-01 | 0.421 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.280398e-01 | 0.277 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.962849e-01 | 0.225 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.788479e-01 | 0.237 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.097446e-01 | 0.960 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.733128e-01 | 0.325 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.381718e-01 | 0.623 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.056459e-01 | 0.687 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.938478e-01 | 0.713 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.724417e-02 | 1.112 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.662172e-01 | 0.779 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.538774e-02 | 1.069 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.120497e-01 | 0.951 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.544685e-01 | 0.811 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.729513e-01 | 0.428 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.053072e-01 | 0.515 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.053072e-01 | 0.515 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.540535e-01 | 0.343 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.622149e-01 | 0.581 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.733547e-01 | 0.563 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.840350e-01 | 0.234 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.939244e-01 | 0.405 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.785357e-01 | 0.422 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.482333e-01 | 0.458 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.203487e-01 | 0.376 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.093686e-01 | 0.510 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.712076e-01 | 0.567 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.431847e-01 | 0.353 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.676952e-01 | 0.572 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.435744e-01 | 0.464 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.588116e-01 | 0.799 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.426622e-01 | 0.846 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 1.662172e-01 | 0.779 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.133517e-01 | 0.671 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.617900e-01 | 0.582 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.642745e-01 | 0.784 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.935211e-01 | 0.532 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.327617e-02 | 1.199 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.895342e-01 | 0.538 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.116511e-01 | 0.674 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.077753e-01 | 0.294 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.167508e-01 | 0.664 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.397559e-01 | 0.855 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.923302e-01 | 0.406 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.406925e-01 | 0.356 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 6.113795e-01 | 0.214 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.962849e-01 | 0.225 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.734943e-01 | 0.241 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 6.424777e-02 | 1.192 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 6.424777e-02 | 1.192 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.724323e-01 | 0.242 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 2.604379e-01 | 0.584 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.640039e-01 | 0.249 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.298273e-01 | 0.482 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.562300e-01 | 0.341 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 3.281643e-01 | 0.484 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.460757e-01 | 0.461 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.392390e-01 | 0.357 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.225060e-01 | 0.282 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.826874e-02 | 1.106 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.874208e-01 | 0.541 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.935211e-01 | 0.532 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.124189e-02 | 1.040 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.905193e-01 | 0.720 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.281643e-01 | 0.484 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.686791e-01 | 0.433 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.771549e-01 | 0.423 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.337086e-01 | 0.477 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.516709e-01 | 0.258 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.592872e-02 | 1.018 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.392390e-01 | 0.357 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 5.198321e-01 | 0.284 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.132657e-01 | 0.212 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.042194e-02 | 1.095 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.711066e-01 | 0.767 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.672325e-01 | 0.777 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.697236e-02 | 1.114 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.198321e-01 | 0.284 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.383327e-01 | 0.859 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.492635e-01 | 0.603 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.109505e-01 | 0.292 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.673264e-01 | 0.573 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.130191e-01 | 0.947 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.282327e-01 | 0.277 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 7.040806e-02 | 1.152 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.463644e-02 | 1.190 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.383327e-01 | 0.859 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.142044e-01 | 0.383 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.846310e-01 | 0.734 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.317415e-01 | 0.635 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.470854e-02 | 1.072 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.626328e-01 | 0.250 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.139644e-01 | 0.383 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.962849e-01 | 0.225 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.927122e-01 | 0.227 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.907631e-01 | 0.229 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.272015e-01 | 0.203 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.770709e-01 | 0.557 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.998307e-01 | 0.523 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.730281e-01 | 0.325 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.480051e-01 | 0.349 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.755897e-01 | 0.560 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.755897e-01 | 0.560 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.153893e-01 | 0.211 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.524653e-02 | 1.069 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.895342e-01 | 0.538 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.927122e-01 | 0.227 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.413133e-01 | 0.850 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.394402e-01 | 0.856 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.771549e-01 | 0.423 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.403714e-01 | 0.619 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.890738e-01 | 0.410 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.910249e-01 | 0.309 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.935211e-01 | 0.532 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.213130e-01 | 0.375 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.896201e-01 | 0.538 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.550436e-01 | 0.450 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.161607e-01 | 0.287 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.983416e-01 | 0.525 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.152747e-01 | 0.501 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.053072e-01 | 0.515 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.319125e-01 | 0.635 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.595751e-01 | 0.444 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.317639e-01 | 0.880 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.460412e-01 | 0.351 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.460412e-01 | 0.351 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.886148e-02 | 1.162 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.077753e-01 | 0.294 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.213130e-01 | 0.375 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 4.512320e-01 | 0.346 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.741859e-01 | 0.427 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.461179e-01 | 0.461 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.948154e-01 | 0.306 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.962849e-01 | 0.225 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.017893e-01 | 0.396 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.386139e-02 | 1.132 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.276126e-02 | 1.202 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.909670e-01 | 0.536 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.281643e-01 | 0.484 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.316873e-01 | 0.880 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.550362e-02 | 1.020 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.023396e-01 | 0.220 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.321176e-01 | 0.479 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.220191e-02 | 1.035 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.152747e-01 | 0.501 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.686791e-01 | 0.433 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.973537e-01 | 0.401 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.186174e-01 | 0.378 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.288042e-01 | 0.277 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.537887e-01 | 0.451 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.444412e-01 | 0.352 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.492635e-01 | 0.603 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.988589e-01 | 0.701 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.881167e-01 | 0.311 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.669924e-01 | 0.574 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.033137e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.001021e-01 | 0.398 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.394191e-01 | 0.469 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.312026e-02 | 1.200 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.896201e-01 | 0.538 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.267225e-01 | 0.486 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.525729e-01 | 0.453 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.242130e-01 | 0.205 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.573836e-01 | 0.447 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.492635e-01 | 0.603 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.584028e-01 | 0.253 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.026378e-01 | 0.989 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.684413e-01 | 0.774 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.439303e-01 | 0.842 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.927040e-01 | 0.227 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.270891e-01 | 0.644 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.850501e-01 | 0.545 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.717032e-01 | 0.326 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.712492e-02 | 1.113 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.620199e-01 | 0.441 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.976408e-02 | 1.001 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.931602e-01 | 0.533 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.135722e-01 | 0.383 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.413133e-01 | 0.850 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.413133e-01 | 0.850 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.296030e-01 | 0.482 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.187863e-01 | 0.925 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.588116e-01 | 0.799 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.008593e-01 | 0.697 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.706639e-01 | 0.768 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.765690e-01 | 0.424 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.765690e-01 | 0.424 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 3.765690e-01 | 0.424 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.765690e-01 | 0.424 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.442188e-01 | 0.841 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.039968e-01 | 0.983 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.874208e-01 | 0.541 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.305431e-01 | 0.637 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.324951e-01 | 0.878 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.460412e-01 | 0.351 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.460412e-01 | 0.351 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.460412e-01 | 0.351 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.672325e-01 | 0.777 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.989327e-01 | 0.701 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.729513e-01 | 0.428 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.729513e-01 | 0.428 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.132988e-01 | 0.946 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.131365e-01 | 0.946 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.574205e-01 | 0.447 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.077753e-01 | 0.294 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 2.749559e-01 | 0.561 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.891455e-01 | 0.410 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.281643e-01 | 0.484 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.540535e-01 | 0.343 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.564262e-01 | 0.448 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.119000e-01 | 0.385 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.906453e-01 | 0.408 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.597178e-01 | 0.338 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.105670e-01 | 0.292 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.800055e-01 | 0.319 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.225060e-01 | 0.282 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.113795e-01 | 0.214 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.113795e-01 | 0.214 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.113795e-01 | 0.214 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.113795e-01 | 0.214 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.113795e-01 | 0.214 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.113795e-01 | 0.214 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.464939e-01 | 0.262 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.698385e-01 | 0.244 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.962849e-01 | 0.225 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.469068e-01 | 0.262 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.927122e-01 | 0.227 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.924964e-01 | 0.227 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.924964e-01 | 0.227 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.121096e-01 | 0.213 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.470214e-01 | 0.607 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.955808e-01 | 0.403 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.145828e-01 | 0.211 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.907631e-01 | 0.229 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.785357e-01 | 0.422 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.137740e-01 | 0.944 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.092345e-01 | 0.962 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.242141e-01 | 0.489 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.853198e-01 | 0.414 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 9.729584e-02 | 1.012 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.439306e-01 | 0.613 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.540535e-01 | 0.343 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.460757e-01 | 0.461 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.850709e-02 | 1.164 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 1.826036e-01 | 0.738 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.317918e-01 | 0.274 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.569204e-01 | 0.254 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.931791e-01 | 0.533 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.985363e-01 | 0.702 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.157756e-01 | 0.501 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.734943e-01 | 0.241 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.202611e-01 | 0.920 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.283546e-01 | 0.368 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.359009e-01 | 0.474 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.458088e-02 | 1.073 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.157756e-01 | 0.501 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.540535e-01 | 0.343 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.512320e-01 | 0.346 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.481399e-01 | 0.458 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.225060e-01 | 0.282 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.009873e-02 | 1.154 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.152747e-01 | 0.501 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.785357e-01 | 0.422 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.698385e-01 | 0.244 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.771340e-01 | 0.239 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.492635e-01 | 0.603 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.855685e-01 | 0.232 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.855685e-01 | 0.232 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.540614e-01 | 0.595 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.439827e-01 | 0.613 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.442188e-01 | 0.841 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.662172e-01 | 0.779 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.874208e-01 | 0.541 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.893139e-01 | 0.723 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.729513e-01 | 0.428 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.729513e-01 | 0.428 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.077753e-01 | 0.294 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.686791e-01 | 0.433 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.626328e-01 | 0.250 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.634814e-01 | 0.249 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.113795e-01 | 0.214 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.113795e-01 | 0.214 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.113795e-01 | 0.214 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.210746e-01 | 0.283 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.923603e-01 | 0.534 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.584406e-01 | 0.253 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.875120e-01 | 0.231 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.587775e-01 | 0.799 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.973537e-01 | 0.401 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.686596e-01 | 0.329 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.381718e-01 | 0.623 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.895342e-01 | 0.538 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.826036e-01 | 0.738 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.386145e-01 | 0.622 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.742721e-01 | 0.427 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.381459e-01 | 0.358 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.804423e-01 | 0.318 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.543109e-01 | 0.343 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.044644e-01 | 0.297 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.052373e-01 | 0.978 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.330996e-01 | 0.632 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.628908e-02 | 1.064 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.060889e-01 | 0.974 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.305431e-01 | 0.637 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.359979e-01 | 0.627 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.891455e-01 | 0.410 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.755897e-01 | 0.560 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.152747e-01 | 0.501 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.686791e-01 | 0.433 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.626328e-01 | 0.250 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.626328e-01 | 0.250 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.975334e-01 | 0.401 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.543109e-01 | 0.343 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.494055e-01 | 0.347 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.113795e-01 | 0.214 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.113795e-01 | 0.214 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.316800e-01 | 0.274 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.663358e-01 | 0.247 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 6.180248e-01 | 0.209 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.219027e-01 | 0.654 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.228257e-01 | 0.491 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.865026e-01 | 0.543 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.973537e-01 | 0.401 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.172850e-01 | 0.931 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.358062e-01 | 0.474 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.240883e-01 | 0.489 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.680993e-01 | 0.246 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.354427e-01 | 0.474 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.663358e-01 | 0.247 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.776351e-01 | 0.321 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.706639e-01 | 0.768 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.039968e-01 | 0.983 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.142529e-01 | 0.383 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.358062e-01 | 0.474 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.142044e-01 | 0.383 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.540535e-01 | 0.343 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 4.922992e-01 | 0.308 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.922992e-01 | 0.308 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.406925e-01 | 0.356 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.935211e-01 | 0.532 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.765989e-01 | 0.558 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.133520e-01 | 0.212 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.966373e-01 | 0.706 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.588116e-01 | 0.799 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.439827e-01 | 0.613 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.765690e-01 | 0.424 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.305684e-01 | 0.481 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.729513e-01 | 0.428 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.077753e-01 | 0.294 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 4.204685e-01 | 0.376 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.626328e-01 | 0.250 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.494055e-01 | 0.347 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.979274e-01 | 0.303 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.634814e-01 | 0.249 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.634814e-01 | 0.249 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.113795e-01 | 0.214 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.113795e-01 | 0.214 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.031729e-01 | 0.298 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.464939e-01 | 0.262 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.966724e-01 | 0.706 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.204685e-01 | 0.376 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.620392e-01 | 0.250 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.979044e-01 | 0.400 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.000574e-01 | 0.301 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.812719e-01 | 0.742 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.053072e-01 | 0.515 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.010660e-01 | 0.697 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.895342e-01 | 0.538 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.813021e-01 | 0.318 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.915779e-01 | 0.308 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.047953e-01 | 0.218 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.597178e-01 | 0.338 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.979274e-01 | 0.303 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.415758e-01 | 0.849 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.234709e-01 | 0.908 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.234709e-01 | 0.908 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.234709e-01 | 0.908 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.729513e-01 | 0.428 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.142044e-01 | 0.383 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 4.540535e-01 | 0.343 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.486170e-01 | 0.458 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.813021e-01 | 0.318 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 4.813021e-01 | 0.318 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.597178e-01 | 0.338 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 6.113795e-01 | 0.214 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 6.113795e-01 | 0.214 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.272015e-01 | 0.203 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.800993e-02 | 1.009 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.953802e-01 | 0.403 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.132657e-01 | 0.212 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.105670e-01 | 0.292 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.634814e-01 | 0.249 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.479979e-01 | 0.830 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.000656e-01 | 0.699 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.785357e-01 | 0.422 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.785357e-01 | 0.422 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.149877e-01 | 0.668 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.472544e-01 | 0.349 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.113795e-01 | 0.214 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.142044e-01 | 0.383 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.005667e-01 | 0.698 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.950872e-01 | 0.403 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.552734e-01 | 0.593 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.486848e-01 | 0.458 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.316800e-01 | 0.274 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.303288e-01 | 0.200 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.305329e-01 | 0.200 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.311823e-01 | 0.200 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.323158e-01 | 0.199 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.346356e-01 | 0.197 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.346356e-01 | 0.197 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.346356e-01 | 0.197 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.346356e-01 | 0.197 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.353582e-01 | 0.197 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.356180e-01 | 0.197 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.356180e-01 | 0.197 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.395961e-01 | 0.194 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.399467e-01 | 0.194 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.422472e-01 | 0.192 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.422472e-01 | 0.192 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.454268e-01 | 0.190 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.461146e-01 | 0.190 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.507813e-01 | 0.187 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.507813e-01 | 0.187 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.507813e-01 | 0.187 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.507813e-01 | 0.187 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.507813e-01 | 0.187 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.526274e-01 | 0.185 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.546956e-01 | 0.184 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.546956e-01 | 0.184 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.546956e-01 | 0.184 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.546956e-01 | 0.184 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.546956e-01 | 0.184 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.546956e-01 | 0.184 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.546956e-01 | 0.184 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.546956e-01 | 0.184 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.546956e-01 | 0.184 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.546956e-01 | 0.184 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.560335e-01 | 0.183 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.562444e-01 | 0.183 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.562444e-01 | 0.183 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.562444e-01 | 0.183 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.562444e-01 | 0.183 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.562444e-01 | 0.183 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.562444e-01 | 0.183 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.562444e-01 | 0.183 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.562444e-01 | 0.183 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.562444e-01 | 0.183 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.562444e-01 | 0.183 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.584276e-01 | 0.181 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.588619e-01 | 0.181 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.588619e-01 | 0.181 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 6.592071e-01 | 0.181 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.600619e-01 | 0.180 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.642596e-01 | 0.178 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.642596e-01 | 0.178 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.642596e-01 | 0.178 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.653649e-01 | 0.177 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.653649e-01 | 0.177 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.653649e-01 | 0.177 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.686467e-01 | 0.175 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 6.704669e-01 | 0.174 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.718153e-01 | 0.173 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.756646e-01 | 0.170 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.756646e-01 | 0.170 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.756646e-01 | 0.170 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.756646e-01 | 0.170 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.756646e-01 | 0.170 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.764673e-01 | 0.170 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.764673e-01 | 0.170 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.815145e-01 | 0.167 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.815145e-01 | 0.167 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.818706e-01 | 0.166 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.834470e-01 | 0.165 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.834470e-01 | 0.165 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.834470e-01 | 0.165 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.834470e-01 | 0.165 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.834470e-01 | 0.165 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.834470e-01 | 0.165 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.834470e-01 | 0.165 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.834470e-01 | 0.165 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.836567e-01 | 0.165 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.853016e-01 | 0.164 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.859009e-01 | 0.164 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.859009e-01 | 0.164 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.859009e-01 | 0.164 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.859009e-01 | 0.164 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.873737e-01 | 0.163 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.873737e-01 | 0.163 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.873737e-01 | 0.163 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 6.924885e-01 | 0.160 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.931859e-01 | 0.159 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.931859e-01 | 0.159 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.931859e-01 | 0.159 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.931859e-01 | 0.159 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.931859e-01 | 0.159 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.931859e-01 | 0.159 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.931859e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.931859e-01 | 0.159 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.931859e-01 | 0.159 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.931859e-01 | 0.159 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.931859e-01 | 0.159 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.931859e-01 | 0.159 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.931859e-01 | 0.159 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.931859e-01 | 0.159 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.931859e-01 | 0.159 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.931859e-01 | 0.159 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.931859e-01 | 0.159 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.931859e-01 | 0.159 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.931859e-01 | 0.159 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.931859e-01 | 0.159 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.945031e-01 | 0.158 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.945031e-01 | 0.158 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.949365e-01 | 0.158 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.971988e-01 | 0.157 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.010446e-01 | 0.154 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.051330e-01 | 0.152 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.082787e-01 | 0.150 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.082787e-01 | 0.150 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.082787e-01 | 0.150 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.088587e-01 | 0.149 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.088587e-01 | 0.149 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 7.088587e-01 | 0.149 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.088587e-01 | 0.149 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.088587e-01 | 0.149 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 7.088587e-01 | 0.149 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.088587e-01 | 0.149 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.088587e-01 | 0.149 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.107347e-01 | 0.148 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.107347e-01 | 0.148 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.125460e-01 | 0.147 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.125460e-01 | 0.147 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.125460e-01 | 0.147 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.133386e-01 | 0.147 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.148366e-01 | 0.146 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.167837e-01 | 0.145 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.167837e-01 | 0.145 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.185490e-01 | 0.144 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.185490e-01 | 0.144 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.186112e-01 | 0.144 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.188172e-01 | 0.143 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.188172e-01 | 0.143 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.220486e-01 | 0.141 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.247311e-01 | 0.140 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.273878e-01 | 0.138 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.273878e-01 | 0.138 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.273878e-01 | 0.138 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.273878e-01 | 0.138 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.273878e-01 | 0.138 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.273878e-01 | 0.138 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.273878e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.273878e-01 | 0.138 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.273878e-01 | 0.138 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.273878e-01 | 0.138 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.276532e-01 | 0.138 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.280922e-01 | 0.138 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.280922e-01 | 0.138 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.280922e-01 | 0.138 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.291786e-01 | 0.137 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.297954e-01 | 0.137 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.325408e-01 | 0.135 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.325408e-01 | 0.135 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.325408e-01 | 0.135 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.325408e-01 | 0.135 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.325408e-01 | 0.135 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.325408e-01 | 0.135 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.325408e-01 | 0.135 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.361477e-01 | 0.133 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.444755e-01 | 0.128 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.448725e-01 | 0.128 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.455707e-01 | 0.128 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.468334e-01 | 0.127 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.468334e-01 | 0.127 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.468334e-01 | 0.127 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.468334e-01 | 0.127 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.485417e-01 | 0.126 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.487046e-01 | 0.126 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.487046e-01 | 0.126 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.487046e-01 | 0.126 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.487046e-01 | 0.126 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.487046e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.487046e-01 | 0.126 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.487046e-01 | 0.126 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.507719e-01 | 0.124 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.538611e-01 | 0.123 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.545629e-01 | 0.122 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.545629e-01 | 0.122 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.545629e-01 | 0.122 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.545629e-01 | 0.122 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.545629e-01 | 0.122 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.577788e-01 | 0.120 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.577788e-01 | 0.120 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.577788e-01 | 0.120 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.577788e-01 | 0.120 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.577788e-01 | 0.120 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 7.577788e-01 | 0.120 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.577788e-01 | 0.120 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.577788e-01 | 0.120 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.577788e-01 | 0.120 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.577788e-01 | 0.120 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.577788e-01 | 0.120 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.577788e-01 | 0.120 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.577788e-01 | 0.120 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.577788e-01 | 0.120 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.577788e-01 | 0.120 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.583639e-01 | 0.120 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 7.619411e-01 | 0.118 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 7.619411e-01 | 0.118 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.628540e-01 | 0.118 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.645265e-01 | 0.117 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.645265e-01 | 0.117 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.647907e-01 | 0.116 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.655357e-01 | 0.116 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.695979e-01 | 0.114 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.707776e-01 | 0.113 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.726439e-01 | 0.112 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.750008e-01 | 0.111 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.750008e-01 | 0.111 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.750008e-01 | 0.111 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.750008e-01 | 0.111 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.750494e-01 | 0.111 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.768602e-01 | 0.110 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.770910e-01 | 0.110 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.812003e-01 | 0.107 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.812003e-01 | 0.107 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.823966e-01 | 0.107 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.847834e-01 | 0.105 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 7.847834e-01 | 0.105 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.847834e-01 | 0.105 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.847834e-01 | 0.105 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.847834e-01 | 0.105 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.847834e-01 | 0.105 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.847834e-01 | 0.105 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.847834e-01 | 0.105 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.847834e-01 | 0.105 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.847834e-01 | 0.105 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.847834e-01 | 0.105 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.847834e-01 | 0.105 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.847834e-01 | 0.105 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.847834e-01 | 0.105 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.847834e-01 | 0.105 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.863813e-01 | 0.104 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.893297e-01 | 0.103 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.910302e-01 | 0.102 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.917358e-01 | 0.101 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.917358e-01 | 0.101 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.939340e-01 | 0.100 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.939340e-01 | 0.100 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.939340e-01 | 0.100 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.939340e-01 | 0.100 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.939340e-01 | 0.100 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.939340e-01 | 0.100 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.939340e-01 | 0.100 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.968870e-01 | 0.099 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.968870e-01 | 0.099 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.968870e-01 | 0.099 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.968870e-01 | 0.099 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.009905e-01 | 0.096 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.013025e-01 | 0.096 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.043507e-01 | 0.095 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.044691e-01 | 0.094 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.044691e-01 | 0.094 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.071329e-01 | 0.093 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.087788e-01 | 0.092 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.087788e-01 | 0.092 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.087788e-01 | 0.092 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.087788e-01 | 0.092 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.087788e-01 | 0.092 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.087788e-01 | 0.092 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 8.087788e-01 | 0.092 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.087788e-01 | 0.092 | 0 | 0 |
| Vitamin B1 (thiamin) metabolism | R-HSA-196819 | 8.087788e-01 | 0.092 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.087788e-01 | 0.092 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.087788e-01 | 0.092 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.087788e-01 | 0.092 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.087788e-01 | 0.092 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.087788e-01 | 0.092 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.098361e-01 | 0.092 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.114438e-01 | 0.091 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 8.114438e-01 | 0.091 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.116214e-01 | 0.091 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.116214e-01 | 0.091 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.122396e-01 | 0.090 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.125940e-01 | 0.090 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.126593e-01 | 0.090 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.130090e-01 | 0.090 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.141765e-01 | 0.089 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.171968e-01 | 0.088 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.171968e-01 | 0.088 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.171968e-01 | 0.088 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.183068e-01 | 0.087 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.207245e-01 | 0.086 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.211173e-01 | 0.086 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.231704e-01 | 0.085 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.254406e-01 | 0.083 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.270994e-01 | 0.082 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.276123e-01 | 0.082 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.276123e-01 | 0.082 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.276123e-01 | 0.082 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.292349e-01 | 0.081 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.301000e-01 | 0.081 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.301000e-01 | 0.081 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.301000e-01 | 0.081 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.301000e-01 | 0.081 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.301000e-01 | 0.081 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.301000e-01 | 0.081 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.301000e-01 | 0.081 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.301000e-01 | 0.081 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.301000e-01 | 0.081 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.301000e-01 | 0.081 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.337752e-01 | 0.079 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.345326e-01 | 0.079 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.383829e-01 | 0.077 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.383829e-01 | 0.077 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.406060e-01 | 0.075 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.411203e-01 | 0.075 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.422231e-01 | 0.075 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.425208e-01 | 0.074 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.425208e-01 | 0.074 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.425208e-01 | 0.074 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.425208e-01 | 0.074 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.425208e-01 | 0.074 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.454083e-01 | 0.073 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.454083e-01 | 0.073 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.489146e-01 | 0.071 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.490450e-01 | 0.071 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.490450e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.490450e-01 | 0.071 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.490450e-01 | 0.071 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.490450e-01 | 0.071 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.490450e-01 | 0.071 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.490450e-01 | 0.071 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.490450e-01 | 0.071 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.490450e-01 | 0.071 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.490450e-01 | 0.071 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.490450e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.494112e-01 | 0.071 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.504874e-01 | 0.070 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.504874e-01 | 0.070 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.504874e-01 | 0.070 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.525801e-01 | 0.069 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.548035e-01 | 0.068 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.562491e-01 | 0.067 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.562491e-01 | 0.067 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.562491e-01 | 0.067 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.562491e-01 | 0.067 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.589783e-01 | 0.066 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.589783e-01 | 0.066 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.597783e-01 | 0.066 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.611426e-01 | 0.065 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.614433e-01 | 0.065 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.614433e-01 | 0.065 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.614433e-01 | 0.065 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.614433e-01 | 0.065 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.617938e-01 | 0.065 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.617938e-01 | 0.065 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.617938e-01 | 0.065 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.627706e-01 | 0.064 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.640981e-01 | 0.063 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.648125e-01 | 0.063 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.658785e-01 | 0.063 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.658785e-01 | 0.063 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.658785e-01 | 0.063 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.658785e-01 | 0.063 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.658785e-01 | 0.063 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.658785e-01 | 0.063 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.658785e-01 | 0.063 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.658785e-01 | 0.063 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.658785e-01 | 0.063 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.658785e-01 | 0.063 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.658785e-01 | 0.063 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.658785e-01 | 0.063 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.658785e-01 | 0.063 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.688751e-01 | 0.061 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.688751e-01 | 0.061 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.688751e-01 | 0.061 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.709586e-01 | 0.060 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.709586e-01 | 0.060 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.723417e-01 | 0.059 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.727074e-01 | 0.059 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.727074e-01 | 0.059 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.760303e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.771722e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.771722e-01 | 0.057 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.788512e-01 | 0.056 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.799051e-01 | 0.056 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.799051e-01 | 0.056 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.799051e-01 | 0.056 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.799051e-01 | 0.056 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.804738e-01 | 0.055 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.804738e-01 | 0.055 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.808358e-01 | 0.055 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.808358e-01 | 0.055 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.808358e-01 | 0.055 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 8.808358e-01 | 0.055 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.808358e-01 | 0.055 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.808358e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.808358e-01 | 0.055 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.808358e-01 | 0.055 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.808358e-01 | 0.055 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.808358e-01 | 0.055 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.808358e-01 | 0.055 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.808358e-01 | 0.055 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.808358e-01 | 0.055 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.808358e-01 | 0.055 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.808358e-01 | 0.055 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.808358e-01 | 0.055 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.808358e-01 | 0.055 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.808358e-01 | 0.055 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.821706e-01 | 0.054 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.821706e-01 | 0.054 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.821706e-01 | 0.054 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.821706e-01 | 0.054 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.828009e-01 | 0.054 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.885428e-01 | 0.051 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.911173e-01 | 0.050 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.911173e-01 | 0.050 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.911173e-01 | 0.050 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.911173e-01 | 0.050 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.911173e-01 | 0.050 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.934593e-01 | 0.049 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.941257e-01 | 0.049 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.941257e-01 | 0.049 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.941257e-01 | 0.049 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.941257e-01 | 0.049 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.941257e-01 | 0.049 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.941257e-01 | 0.049 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.941257e-01 | 0.049 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.941257e-01 | 0.049 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 8.941257e-01 | 0.049 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.941257e-01 | 0.049 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.941257e-01 | 0.049 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.941257e-01 | 0.049 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.941257e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.951555e-01 | 0.048 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.958048e-01 | 0.048 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.961919e-01 | 0.048 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.987244e-01 | 0.046 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.998256e-01 | 0.046 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.003079e-01 | 0.046 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.003870e-01 | 0.046 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.008743e-01 | 0.045 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.030863e-01 | 0.044 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.035401e-01 | 0.044 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.059342e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.059342e-01 | 0.043 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.059342e-01 | 0.043 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.059342e-01 | 0.043 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.059342e-01 | 0.043 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.059342e-01 | 0.043 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.059342e-01 | 0.043 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.059342e-01 | 0.043 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 9.059342e-01 | 0.043 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.059342e-01 | 0.043 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.059342e-01 | 0.043 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.059342e-01 | 0.043 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.059342e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.077268e-01 | 0.042 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.078864e-01 | 0.042 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.091069e-01 | 0.041 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.098101e-01 | 0.041 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.110170e-01 | 0.040 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.150586e-01 | 0.039 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.150586e-01 | 0.039 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.151824e-01 | 0.038 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.152052e-01 | 0.038 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.152052e-01 | 0.038 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.164263e-01 | 0.038 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.164263e-01 | 0.038 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.164263e-01 | 0.038 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.164263e-01 | 0.038 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.164263e-01 | 0.038 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.164263e-01 | 0.038 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.164263e-01 | 0.038 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.164263e-01 | 0.038 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.164263e-01 | 0.038 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.164263e-01 | 0.038 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.169776e-01 | 0.038 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.179865e-01 | 0.037 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.197950e-01 | 0.036 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.211397e-01 | 0.036 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.212522e-01 | 0.036 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.218559e-01 | 0.035 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.254617e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.254617e-01 | 0.034 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.254617e-01 | 0.034 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.254617e-01 | 0.034 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.254617e-01 | 0.034 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.256220e-01 | 0.034 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.256220e-01 | 0.034 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.256220e-01 | 0.034 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.257486e-01 | 0.034 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.257486e-01 | 0.034 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.257486e-01 | 0.034 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.257486e-01 | 0.034 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.257486e-01 | 0.034 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.257486e-01 | 0.034 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.257486e-01 | 0.034 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.257486e-01 | 0.034 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.257486e-01 | 0.034 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.257486e-01 | 0.034 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.257486e-01 | 0.034 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.270937e-01 | 0.033 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.281519e-01 | 0.032 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.281519e-01 | 0.032 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.281519e-01 | 0.032 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.286834e-01 | 0.032 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.313136e-01 | 0.031 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.322902e-01 | 0.030 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.322902e-01 | 0.030 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.322902e-01 | 0.030 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.322902e-01 | 0.030 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.322902e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.339786e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.340315e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.340315e-01 | 0.030 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.340315e-01 | 0.030 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.340315e-01 | 0.030 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.340315e-01 | 0.030 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.340315e-01 | 0.030 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.340315e-01 | 0.030 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.340315e-01 | 0.030 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.353571e-01 | 0.029 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.362423e-01 | 0.029 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.413909e-01 | 0.026 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.413909e-01 | 0.026 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.413909e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.413909e-01 | 0.026 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.413909e-01 | 0.026 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.413909e-01 | 0.026 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.413909e-01 | 0.026 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.413909e-01 | 0.026 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.413909e-01 | 0.026 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.413909e-01 | 0.026 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.413909e-01 | 0.026 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.413909e-01 | 0.026 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.413909e-01 | 0.026 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.413909e-01 | 0.026 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.434614e-01 | 0.025 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.442091e-01 | 0.025 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.446311e-01 | 0.025 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.462576e-01 | 0.024 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.479297e-01 | 0.023 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.479297e-01 | 0.023 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.479297e-01 | 0.023 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.479297e-01 | 0.023 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.479297e-01 | 0.023 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.479297e-01 | 0.023 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.479297e-01 | 0.023 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.479297e-01 | 0.023 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.489411e-01 | 0.023 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.490098e-01 | 0.023 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.493917e-01 | 0.023 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.493917e-01 | 0.023 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.521872e-01 | 0.021 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.526288e-01 | 0.021 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.537393e-01 | 0.021 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.537393e-01 | 0.021 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.537393e-01 | 0.021 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.537393e-01 | 0.021 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.537393e-01 | 0.021 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.537393e-01 | 0.021 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.537393e-01 | 0.021 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.537393e-01 | 0.021 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.537393e-01 | 0.021 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.537393e-01 | 0.021 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.541128e-01 | 0.020 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.541128e-01 | 0.020 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.541128e-01 | 0.020 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.545167e-01 | 0.020 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.553899e-01 | 0.020 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.553899e-01 | 0.020 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.555957e-01 | 0.020 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.555957e-01 | 0.020 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.558549e-01 | 0.020 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.570910e-01 | 0.019 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.570910e-01 | 0.019 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.570910e-01 | 0.019 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.578425e-01 | 0.019 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.578425e-01 | 0.019 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.578425e-01 | 0.019 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.584108e-01 | 0.018 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.584108e-01 | 0.018 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.584108e-01 | 0.018 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.589010e-01 | 0.018 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.589010e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.589010e-01 | 0.018 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.589010e-01 | 0.018 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.589010e-01 | 0.018 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.589010e-01 | 0.018 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.589010e-01 | 0.018 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 9.589010e-01 | 0.018 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.590102e-01 | 0.018 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.592857e-01 | 0.018 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.601007e-01 | 0.018 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.613663e-01 | 0.017 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.620029e-01 | 0.017 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.620029e-01 | 0.017 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.620029e-01 | 0.017 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.623213e-01 | 0.017 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.623213e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.634871e-01 | 0.016 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.634871e-01 | 0.016 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.634871e-01 | 0.016 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.634871e-01 | 0.016 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.634871e-01 | 0.016 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.634871e-01 | 0.016 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.634871e-01 | 0.016 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.634871e-01 | 0.016 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.634871e-01 | 0.016 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.634871e-01 | 0.016 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.634871e-01 | 0.016 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.640089e-01 | 0.016 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.641276e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.642979e-01 | 0.016 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.649570e-01 | 0.015 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.649570e-01 | 0.015 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.658772e-01 | 0.015 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.658772e-01 | 0.015 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.658772e-01 | 0.015 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.658772e-01 | 0.015 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.675072e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.675616e-01 | 0.014 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.675616e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.675616e-01 | 0.014 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.675616e-01 | 0.014 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.675616e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.675616e-01 | 0.014 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.684711e-01 | 0.014 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.691090e-01 | 0.014 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.698659e-01 | 0.013 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.698659e-01 | 0.013 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.711817e-01 | 0.013 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.711817e-01 | 0.013 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.711817e-01 | 0.013 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.711817e-01 | 0.013 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.711817e-01 | 0.013 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.716995e-01 | 0.012 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.720447e-01 | 0.012 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.720447e-01 | 0.012 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.720447e-01 | 0.012 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.724445e-01 | 0.012 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.724445e-01 | 0.012 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.724445e-01 | 0.012 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.741519e-01 | 0.011 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.743979e-01 | 0.011 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.743979e-01 | 0.011 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.743979e-01 | 0.011 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.743979e-01 | 0.011 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.743979e-01 | 0.011 | 0 | 0 |
| Retinoid cycle disease events | R-HSA-2453864 | 9.743979e-01 | 0.011 | 0 | 0 |
| Diseases of the neuronal system | R-HSA-9675143 | 9.743979e-01 | 0.011 | 0 | 0 |
| Diseases associated with visual transduction | R-HSA-2474795 | 9.743979e-01 | 0.011 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.745516e-01 | 0.011 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.745516e-01 | 0.011 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.747101e-01 | 0.011 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.747101e-01 | 0.011 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.747101e-01 | 0.011 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.747618e-01 | 0.011 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.748128e-01 | 0.011 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.756957e-01 | 0.011 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.771290e-01 | 0.010 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.772554e-01 | 0.010 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.776397e-01 | 0.010 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.779166e-01 | 0.010 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.781276e-01 | 0.010 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.789816e-01 | 0.009 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.790310e-01 | 0.009 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.793232e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.793232e-01 | 0.009 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.797941e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.797941e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.797941e-01 | 0.009 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.797941e-01 | 0.009 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.797941e-01 | 0.009 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.797941e-01 | 0.009 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.797941e-01 | 0.009 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.813126e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.813126e-01 | 0.008 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.819365e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.820496e-01 | 0.008 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.820496e-01 | 0.008 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.820496e-01 | 0.008 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.820496e-01 | 0.008 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.824873e-01 | 0.008 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.831157e-01 | 0.007 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.831157e-01 | 0.007 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.835033e-01 | 0.007 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.840231e-01 | 0.007 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.840534e-01 | 0.007 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.840534e-01 | 0.007 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.840534e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.840534e-01 | 0.007 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.840534e-01 | 0.007 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.840534e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.846043e-01 | 0.007 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.846043e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.847493e-01 | 0.007 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.847493e-01 | 0.007 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.854294e-01 | 0.006 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.858337e-01 | 0.006 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.858337e-01 | 0.006 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.860120e-01 | 0.006 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.862287e-01 | 0.006 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.862287e-01 | 0.006 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.864982e-01 | 0.006 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.867165e-01 | 0.006 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.867165e-01 | 0.006 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.867165e-01 | 0.006 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.867165e-01 | 0.006 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.867165e-01 | 0.006 | 1 | 1 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.874153e-01 | 0.006 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.874153e-01 | 0.006 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.874153e-01 | 0.006 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.875679e-01 | 0.005 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.875679e-01 | 0.005 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.881792e-01 | 0.005 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.882222e-01 | 0.005 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.882293e-01 | 0.005 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.887799e-01 | 0.005 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.887799e-01 | 0.005 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.888204e-01 | 0.005 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.888204e-01 | 0.005 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.889708e-01 | 0.005 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.898752e-01 | 0.004 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.898763e-01 | 0.004 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.898763e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.899371e-01 | 0.004 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.899550e-01 | 0.004 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.900686e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.900969e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.903338e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.905658e-01 | 0.004 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.908678e-01 | 0.004 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.908678e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.909237e-01 | 0.004 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.911776e-01 | 0.004 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.911776e-01 | 0.004 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.911776e-01 | 0.004 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.917642e-01 | 0.004 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.921628e-01 | 0.003 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.921628e-01 | 0.003 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.921628e-01 | 0.003 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.921628e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.921628e-01 | 0.003 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.921628e-01 | 0.003 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.925744e-01 | 0.003 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.927324e-01 | 0.003 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.927793e-01 | 0.003 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.930380e-01 | 0.003 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.930380e-01 | 0.003 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.930380e-01 | 0.003 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.930380e-01 | 0.003 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.930380e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.931096e-01 | 0.003 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.931961e-01 | 0.003 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.934260e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.938156e-01 | 0.003 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.938156e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.938892e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.941586e-01 | 0.003 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.945063e-01 | 0.002 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.945063e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.945063e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.945063e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.945063e-01 | 0.002 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.945645e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.948222e-01 | 0.002 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.949684e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.951035e-01 | 0.002 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.951035e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.955899e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.955899e-01 | 0.002 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.956651e-01 | 0.002 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.956651e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.959947e-01 | 0.002 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.960288e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.961493e-01 | 0.002 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.964757e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.965259e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.965406e-01 | 0.002 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.965795e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.965795e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.965795e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.965795e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.966242e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.967545e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.968008e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.968057e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.969617e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.972844e-01 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.973011e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.973938e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.974800e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.976106e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.976106e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.978397e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.978397e-01 | 0.001 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.978706e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.978706e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.978706e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.978778e-01 | 0.001 | 0 | 0 |
| The canonical retinoid cycle in rods (twilight vision) | R-HSA-2453902 | 9.981085e-01 | 0.001 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.981085e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.981085e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.983199e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.985077e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986215e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.986215e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.986745e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.987610e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.988226e-01 | 0.001 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.988226e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.988931e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989542e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.989733e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.989995e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.989995e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.990161e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.990711e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.990711e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.990746e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.991012e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.991012e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.991012e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.991012e-01 | 0.000 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.991733e-01 | 0.000 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.991750e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.991926e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.992672e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992748e-01 | 0.000 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.993492e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.994219e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.994866e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.995200e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.995440e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.995596e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.995770e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.995770e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996203e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.996203e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.996403e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.996403e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.996805e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.996805e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997056e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.997489e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997598e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.997706e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997762e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.997831e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998012e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.998012e-01 | 0.000 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.998225e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998235e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998326e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998408e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998559e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.998763e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.998853e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.998997e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.999055e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999085e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.999134e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.999223e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999231e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999300e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999369e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.999382e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999461e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999573e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999591e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999669e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999669e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999680e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999736e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999736e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999743e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999769e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999789e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999837e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999842e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999885e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999919e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999932e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999951e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999954e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999961e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999974e-01 | 0.000 | 1 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999976e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999978e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999979e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999981e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999985e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999985e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999993e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999995e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999998e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.547918e-15 | 14.020 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.109424e-14 | 13.676 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.341771e-14 | 13.476 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.961898e-14 | 13.225 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.406964e-13 | 12.619 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.539036e-13 | 12.020 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.274425e-12 | 11.895 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.378031e-12 | 11.269 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 8.521184e-12 | 11.070 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.170641e-11 | 10.932 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.277423e-11 | 10.894 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.476086e-11 | 10.831 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.158830e-10 | 9.936 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.442740e-10 | 9.612 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.314838e-10 | 9.480 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.221462e-10 | 9.282 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.987822e-10 | 9.046 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.163839e-09 | 8.934 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.508038e-09 | 8.822 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.597262e-09 | 8.585 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.852286e-09 | 8.545 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.626085e-09 | 8.335 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.839055e-09 | 8.165 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.839055e-09 | 8.165 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.471218e-09 | 8.127 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.115407e-09 | 8.091 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.255634e-09 | 8.083 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.027924e-08 | 7.988 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.082702e-08 | 7.965 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.555763e-08 | 7.808 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.555763e-08 | 7.808 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.603940e-08 | 7.795 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.884344e-08 | 7.725 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.884344e-08 | 7.725 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.843846e-08 | 7.734 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.816694e-08 | 7.550 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.063431e-08 | 7.514 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.144004e-08 | 7.383 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.189857e-08 | 7.378 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.327165e-08 | 7.199 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.660638e-08 | 7.176 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.856389e-08 | 7.164 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.294617e-07 | 6.888 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.294617e-07 | 6.888 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.427234e-07 | 6.846 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.492555e-07 | 6.826 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.566305e-07 | 6.805 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.759141e-07 | 6.755 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.413431e-07 | 6.617 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.714451e-07 | 6.566 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.166595e-07 | 6.499 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.149458e-07 | 6.382 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.182703e-07 | 6.285 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.386991e-07 | 6.269 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.133872e-07 | 6.212 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.952540e-07 | 6.158 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.598639e-07 | 6.066 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.075645e-06 | 5.968 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.230078e-06 | 5.910 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.302443e-06 | 5.885 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.302443e-06 | 5.885 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.887525e-06 | 5.724 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.902719e-06 | 5.721 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.943678e-06 | 5.711 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.216036e-06 | 5.654 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.061827e-06 | 5.514 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.107066e-06 | 5.508 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.329911e-06 | 5.478 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.332677e-06 | 5.477 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.796380e-06 | 5.421 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.999858e-06 | 5.398 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.111804e-06 | 5.386 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.262866e-06 | 5.370 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.459276e-06 | 5.351 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.688985e-06 | 5.329 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.913907e-06 | 5.228 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.188292e-06 | 5.208 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.635274e-06 | 5.064 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 8.991163e-06 | 5.046 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.077990e-05 | 4.967 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.144770e-05 | 4.941 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.257371e-05 | 4.901 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.257371e-05 | 4.901 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.403972e-05 | 4.853 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.472099e-05 | 4.832 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.496712e-05 | 4.825 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.499218e-05 | 4.824 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.811532e-05 | 4.742 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.029408e-05 | 4.693 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.501174e-05 | 4.602 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.377195e-05 | 4.624 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.377195e-05 | 4.624 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 2.396133e-05 | 4.620 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.577537e-05 | 4.589 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.844359e-05 | 4.546 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.299084e-05 | 4.482 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.549346e-05 | 4.450 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.603997e-05 | 4.443 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.787634e-05 | 4.422 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.904700e-05 | 4.408 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.914850e-05 | 4.407 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.267769e-05 | 4.370 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.059317e-05 | 4.392 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.409246e-05 | 4.356 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.600310e-05 | 4.337 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.202581e-05 | 4.284 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.420953e-05 | 4.266 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.750365e-05 | 4.240 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.515160e-05 | 4.186 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.190030e-05 | 4.143 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.823679e-05 | 4.166 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.220605e-05 | 4.141 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.253827e-05 | 4.139 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.453054e-05 | 4.128 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.821257e-05 | 4.054 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.373485e-05 | 4.028 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.347036e-04 | 3.871 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.437978e-04 | 3.842 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.661933e-04 | 3.779 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.694734e-04 | 3.771 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.707412e-04 | 3.768 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.763969e-04 | 3.754 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.909678e-04 | 3.719 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.980366e-04 | 3.703 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.980366e-04 | 3.703 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.962985e-04 | 3.707 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.952154e-04 | 3.709 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.839577e-04 | 3.735 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.909678e-04 | 3.719 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.011585e-04 | 3.696 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.060053e-04 | 3.686 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.180960e-04 | 3.661 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.210409e-04 | 3.656 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.255998e-04 | 3.647 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.267293e-04 | 3.644 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.496866e-04 | 3.603 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.543220e-04 | 3.595 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.543220e-04 | 3.595 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.780963e-04 | 3.556 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.803472e-04 | 3.552 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.164555e-04 | 3.500 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.241267e-04 | 3.489 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.241267e-04 | 3.489 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.277946e-04 | 3.484 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.430316e-04 | 3.465 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.473962e-04 | 3.459 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.473962e-04 | 3.459 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.608803e-04 | 3.443 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.608803e-04 | 3.443 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.781620e-04 | 3.422 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.781620e-04 | 3.422 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.852160e-04 | 3.414 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.808874e-04 | 3.419 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.040500e-04 | 3.394 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.875533e-04 | 3.412 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.169148e-04 | 3.380 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.377811e-04 | 3.359 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.398796e-04 | 3.357 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.584976e-04 | 3.339 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.708023e-04 | 3.327 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.980790e-04 | 3.303 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.101699e-04 | 3.292 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.341621e-04 | 3.272 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.119195e-04 | 3.213 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.119195e-04 | 3.213 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.119195e-04 | 3.213 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.113062e-04 | 3.214 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.900003e-04 | 3.229 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.119195e-04 | 3.213 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.646907e-04 | 3.248 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.889729e-04 | 3.230 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.054054e-04 | 3.218 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.635538e-04 | 3.249 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.303281e-04 | 3.200 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.331180e-04 | 3.199 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.652461e-04 | 3.177 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.842321e-04 | 3.165 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.898230e-04 | 3.161 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.013435e-04 | 3.154 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.081144e-04 | 3.150 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.097038e-04 | 3.149 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.170353e-04 | 3.144 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.521016e-04 | 3.124 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.936026e-04 | 3.100 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.455765e-04 | 3.073 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.663251e-04 | 3.062 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 9.098320e-04 | 3.041 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.379443e-04 | 3.028 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.422324e-04 | 3.026 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.081810e-03 | 2.966 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.026952e-03 | 2.988 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.081810e-03 | 2.966 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.081810e-03 | 2.966 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.081810e-03 | 2.966 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.136605e-03 | 2.944 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.140547e-03 | 2.943 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.189743e-03 | 2.925 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.203855e-03 | 2.919 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.246682e-03 | 2.904 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.288891e-03 | 2.890 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.339998e-03 | 2.873 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.339998e-03 | 2.873 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.340475e-03 | 2.873 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.418540e-03 | 2.848 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.425280e-03 | 2.846 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.453531e-03 | 2.838 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.512578e-03 | 2.820 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.544241e-03 | 2.811 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.617348e-03 | 2.791 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.032834e-03 | 2.692 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.032834e-03 | 2.692 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.787090e-03 | 2.748 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.939793e-03 | 2.712 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.839469e-03 | 2.735 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.116194e-03 | 2.674 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.256470e-03 | 2.647 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.290812e-03 | 2.640 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.318221e-03 | 2.635 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.372891e-03 | 2.625 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.379285e-03 | 2.624 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.379285e-03 | 2.624 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.411165e-03 | 2.618 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.428331e-03 | 2.615 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.484982e-03 | 2.605 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.484982e-03 | 2.605 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.564860e-03 | 2.591 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.570597e-03 | 2.590 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.678837e-03 | 2.572 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.687336e-03 | 2.571 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.725272e-03 | 2.565 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.751805e-03 | 2.560 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.756164e-03 | 2.560 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.763575e-03 | 2.559 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.796834e-03 | 2.553 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.844962e-03 | 2.546 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.935068e-03 | 2.532 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.949130e-03 | 2.530 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.560327e-03 | 2.449 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.245878e-03 | 2.489 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.103674e-03 | 2.508 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.061868e-03 | 2.514 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.282082e-03 | 2.484 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.560327e-03 | 2.449 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.364865e-03 | 2.473 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.103674e-03 | 2.508 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.372730e-03 | 2.472 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.752405e-03 | 2.426 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.797036e-03 | 2.421 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.801203e-03 | 2.420 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.864460e-03 | 2.413 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.876498e-03 | 2.412 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.876498e-03 | 2.412 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.876498e-03 | 2.412 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.975386e-03 | 2.401 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.997950e-03 | 2.398 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.035337e-03 | 2.394 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.095885e-03 | 2.388 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.162105e-03 | 2.381 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.343380e-03 | 2.362 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.364544e-03 | 2.360 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.659400e-03 | 2.332 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.700928e-03 | 2.328 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.700928e-03 | 2.328 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.788933e-03 | 2.320 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.947806e-03 | 2.306 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.947806e-03 | 2.306 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.947806e-03 | 2.306 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.091630e-03 | 2.293 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.113365e-03 | 2.291 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.499288e-03 | 2.260 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.954907e-03 | 2.225 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.695988e-03 | 2.174 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.695988e-03 | 2.174 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.695988e-03 | 2.174 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.695988e-03 | 2.174 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.695988e-03 | 2.174 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.046355e-03 | 2.219 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.046355e-03 | 2.219 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.046355e-03 | 2.219 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.604501e-03 | 2.251 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.561665e-03 | 2.183 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.572600e-03 | 2.182 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.695988e-03 | 2.174 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 5.954907e-03 | 2.225 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.287267e-03 | 2.202 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.401737e-03 | 2.194 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.401737e-03 | 2.194 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.917112e-03 | 2.160 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.998533e-03 | 2.155 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.998533e-03 | 2.155 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.998533e-03 | 2.155 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.493549e-03 | 2.125 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.493549e-03 | 2.125 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.737825e-03 | 2.111 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.866935e-03 | 2.104 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.893945e-03 | 2.103 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.924673e-03 | 2.101 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.472447e-03 | 2.072 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.472447e-03 | 2.072 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.804792e-03 | 2.055 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.853308e-03 | 2.053 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.862508e-03 | 2.052 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.023864e-03 | 2.045 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.035234e-03 | 2.044 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.187058e-03 | 2.037 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.355347e-03 | 2.029 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.455793e-03 | 2.024 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.794756e-03 | 2.009 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.794756e-03 | 2.009 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.794756e-03 | 2.009 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.146710e-02 | 1.941 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.095754e-02 | 1.960 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.123585e-02 | 1.949 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.123585e-02 | 1.949 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.038365e-02 | 1.984 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.175794e-02 | 1.930 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.175794e-02 | 1.930 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.065494e-02 | 1.972 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.146710e-02 | 1.941 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.204919e-02 | 1.919 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.146710e-02 | 1.941 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.123585e-02 | 1.949 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.049770e-02 | 1.979 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.146710e-02 | 1.941 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.204919e-02 | 1.919 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.096263e-02 | 1.960 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.084080e-02 | 1.965 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.150100e-02 | 1.939 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.046237e-02 | 1.980 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.149040e-02 | 1.940 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.240893e-02 | 1.906 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.244786e-02 | 1.905 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.259079e-02 | 1.900 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.264652e-02 | 1.898 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.275950e-02 | 1.894 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.279804e-02 | 1.893 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.293584e-02 | 1.888 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.293584e-02 | 1.888 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.293584e-02 | 1.888 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.326543e-02 | 1.877 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.340753e-02 | 1.873 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.382469e-02 | 1.859 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.422250e-02 | 1.847 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.458267e-02 | 1.836 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.458267e-02 | 1.836 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.458267e-02 | 1.836 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.458267e-02 | 1.836 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.458267e-02 | 1.836 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.477556e-02 | 1.830 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.477556e-02 | 1.830 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.477556e-02 | 1.830 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.477754e-02 | 1.830 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.492472e-02 | 1.826 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.492472e-02 | 1.826 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.503089e-02 | 1.823 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.553999e-02 | 1.809 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.554921e-02 | 1.808 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.554921e-02 | 1.808 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.574424e-02 | 1.803 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.579102e-02 | 1.802 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.580352e-02 | 1.801 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.641492e-02 | 1.785 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.641492e-02 | 1.785 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.641492e-02 | 1.785 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.654973e-02 | 1.781 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.673386e-02 | 1.776 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.673386e-02 | 1.776 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.681763e-02 | 1.774 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.701994e-02 | 1.769 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.701994e-02 | 1.769 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.828873e-02 | 1.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.828873e-02 | 1.738 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.828873e-02 | 1.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.828873e-02 | 1.738 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.828873e-02 | 1.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.828873e-02 | 1.738 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.041794e-02 | 1.690 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.041794e-02 | 1.690 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.041794e-02 | 1.690 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.824250e-02 | 1.739 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.248550e-02 | 1.648 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.889357e-02 | 1.724 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.224931e-02 | 1.653 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.032208e-02 | 1.692 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.248550e-02 | 1.648 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.034259e-02 | 1.692 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.034259e-02 | 1.692 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.034259e-02 | 1.692 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.075347e-02 | 1.683 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.037578e-02 | 1.691 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.824250e-02 | 1.739 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.224931e-02 | 1.653 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.037870e-02 | 1.691 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.224931e-02 | 1.653 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.868188e-02 | 1.729 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.909518e-02 | 1.719 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.022028e-02 | 1.694 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.992396e-02 | 1.701 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.909518e-02 | 1.719 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.283880e-02 | 1.641 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.295053e-02 | 1.639 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.386507e-02 | 1.622 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.412561e-02 | 1.618 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.449933e-02 | 1.611 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.449933e-02 | 1.611 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.449933e-02 | 1.611 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.449933e-02 | 1.611 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.486182e-02 | 1.604 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.526115e-02 | 1.598 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.526115e-02 | 1.598 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.526115e-02 | 1.598 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.526115e-02 | 1.598 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.566801e-02 | 1.591 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.566801e-02 | 1.591 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.566801e-02 | 1.591 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.566801e-02 | 1.591 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.566801e-02 | 1.591 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.566801e-02 | 1.591 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.573739e-02 | 1.589 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.573739e-02 | 1.589 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.573739e-02 | 1.589 | 0 | 0 |
| Translation | R-HSA-72766 | 2.575295e-02 | 1.589 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.582015e-02 | 1.588 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.588998e-02 | 1.587 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.588998e-02 | 1.587 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.734641e-02 | 1.563 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.761421e-02 | 1.559 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.761421e-02 | 1.559 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.761421e-02 | 1.559 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.761421e-02 | 1.559 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.761421e-02 | 1.559 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.763647e-02 | 1.559 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.763647e-02 | 1.559 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.763647e-02 | 1.559 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.763647e-02 | 1.559 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.763647e-02 | 1.559 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.800743e-02 | 1.553 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.836610e-02 | 1.547 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.855484e-02 | 1.544 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.855484e-02 | 1.544 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.878041e-02 | 1.541 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.878041e-02 | 1.541 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.878041e-02 | 1.541 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.934804e-02 | 1.532 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.945757e-02 | 1.531 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.987343e-02 | 1.525 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.987343e-02 | 1.525 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.009903e-02 | 1.521 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.094152e-02 | 1.509 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.126543e-02 | 1.505 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.134916e-02 | 1.504 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.134916e-02 | 1.504 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.144305e-02 | 1.502 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.144305e-02 | 1.502 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.144305e-02 | 1.502 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.168784e-02 | 1.499 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.178271e-02 | 1.498 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.178271e-02 | 1.498 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.204243e-02 | 1.494 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.213351e-02 | 1.493 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.214240e-02 | 1.493 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.214240e-02 | 1.493 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.285529e-02 | 1.483 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.297577e-02 | 1.482 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.305558e-02 | 1.481 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.331242e-02 | 1.477 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.331242e-02 | 1.477 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.434366e-02 | 1.464 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.497249e-02 | 1.456 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.498062e-02 | 1.456 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.520700e-02 | 1.453 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.524884e-02 | 1.453 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.562582e-02 | 1.448 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.562582e-02 | 1.448 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.603509e-02 | 1.443 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.603509e-02 | 1.443 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.613073e-02 | 1.442 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.613073e-02 | 1.442 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.613073e-02 | 1.442 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.619765e-02 | 1.441 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.620208e-02 | 1.441 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.638761e-02 | 1.439 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.638761e-02 | 1.439 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.702693e-02 | 1.431 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.702693e-02 | 1.431 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.849159e-02 | 1.415 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.849540e-02 | 1.415 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.903713e-02 | 1.409 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.903713e-02 | 1.409 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.924640e-02 | 1.406 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.924640e-02 | 1.406 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.924640e-02 | 1.406 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.944048e-02 | 1.404 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.944048e-02 | 1.404 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.017502e-02 | 1.396 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.017502e-02 | 1.396 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.024336e-02 | 1.395 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.010991e-02 | 1.300 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.010991e-02 | 1.300 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.612310e-02 | 1.336 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.591157e-02 | 1.338 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.349278e-02 | 1.272 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.604976e-02 | 1.251 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.040196e-02 | 1.298 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.040196e-02 | 1.298 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.040196e-02 | 1.298 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.667581e-02 | 1.247 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.837195e-02 | 1.315 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.678757e-02 | 1.330 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.678757e-02 | 1.330 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.776002e-02 | 1.238 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.820993e-02 | 1.317 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.040196e-02 | 1.298 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.485198e-02 | 1.261 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.914768e-02 | 1.308 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.281044e-02 | 1.368 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.460850e-02 | 1.351 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.750370e-02 | 1.240 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.750370e-02 | 1.240 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.040772e-02 | 1.219 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.010991e-02 | 1.300 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.040196e-02 | 1.298 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.591157e-02 | 1.338 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.162938e-02 | 1.381 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.427613e-02 | 1.354 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.741102e-02 | 1.241 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.040196e-02 | 1.298 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.115120e-02 | 1.291 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.776919e-02 | 1.321 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.811343e-02 | 1.236 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.510185e-02 | 1.346 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.964378e-02 | 1.304 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.352673e-02 | 1.271 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.041613e-02 | 1.297 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.578341e-02 | 1.253 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.612310e-02 | 1.336 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.041613e-02 | 1.297 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.767964e-02 | 1.322 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.667581e-02 | 1.247 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.404216e-02 | 1.267 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.604976e-02 | 1.251 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.604976e-02 | 1.251 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.964378e-02 | 1.304 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.964378e-02 | 1.304 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.612310e-02 | 1.336 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.130438e-02 | 1.290 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.092937e-02 | 1.215 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.118561e-02 | 1.213 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.178931e-02 | 1.209 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.178931e-02 | 1.209 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.223878e-02 | 1.206 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.223878e-02 | 1.206 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.249902e-02 | 1.204 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.342407e-02 | 1.198 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.342407e-02 | 1.198 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.342407e-02 | 1.198 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.406042e-02 | 1.193 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.406042e-02 | 1.193 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.406042e-02 | 1.193 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.406042e-02 | 1.193 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.587289e-02 | 1.181 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.587289e-02 | 1.181 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.631992e-02 | 1.178 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.631992e-02 | 1.178 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.698793e-02 | 1.174 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.698793e-02 | 1.174 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.761363e-02 | 1.170 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.926247e-02 | 1.160 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.926247e-02 | 1.160 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.003850e-02 | 1.155 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.003850e-02 | 1.155 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.003850e-02 | 1.155 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.065165e-02 | 1.151 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.080421e-02 | 1.150 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.080421e-02 | 1.150 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.157589e-02 | 1.145 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.157589e-02 | 1.145 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.526739e-02 | 1.123 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.697323e-02 | 1.114 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.708757e-02 | 1.113 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.804899e-02 | 1.108 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.804899e-02 | 1.108 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.824010e-02 | 1.107 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.836116e-02 | 1.106 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.905060e-02 | 1.102 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.020510e-02 | 1.096 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 8.053506e-02 | 1.094 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.303548e-02 | 1.081 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.303548e-02 | 1.081 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.396408e-02 | 1.076 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.396408e-02 | 1.076 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.396408e-02 | 1.076 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.396408e-02 | 1.076 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.396408e-02 | 1.076 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.396408e-02 | 1.076 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.460067e-02 | 1.073 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.460067e-02 | 1.073 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.619246e-02 | 1.065 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.639568e-02 | 1.064 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.655288e-02 | 1.063 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.655288e-02 | 1.063 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.823586e-02 | 1.054 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.940950e-02 | 1.049 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.944734e-02 | 1.048 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.944734e-02 | 1.048 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.984837e-02 | 1.046 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.002717e-02 | 1.046 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.002717e-02 | 1.046 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.002717e-02 | 1.046 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.375127e-02 | 1.028 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.375127e-02 | 1.028 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.375127e-02 | 1.028 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 9.375127e-02 | 1.028 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.601782e-02 | 1.018 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 9.728136e-02 | 1.012 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 9.728136e-02 | 1.012 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 9.728136e-02 | 1.012 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.728136e-02 | 1.012 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.728136e-02 | 1.012 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 9.728136e-02 | 1.012 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 9.728136e-02 | 1.012 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 9.728136e-02 | 1.012 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 9.728136e-02 | 1.012 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 9.728136e-02 | 1.012 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 9.728136e-02 | 1.012 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.896364e-02 | 1.005 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.896364e-02 | 1.005 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.896364e-02 | 1.005 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.918325e-02 | 1.004 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.047627e-01 | 0.980 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.075424e-01 | 0.968 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.087992e-01 | 0.963 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.095173e-01 | 0.961 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.095173e-01 | 0.961 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.095173e-01 | 0.961 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.123012e-01 | 0.950 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.127481e-01 | 0.948 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.139219e-01 | 0.943 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.139219e-01 | 0.943 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.139897e-01 | 0.943 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.154664e-01 | 0.938 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.154664e-01 | 0.938 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.166228e-01 | 0.933 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.166228e-01 | 0.933 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.166228e-01 | 0.933 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.166228e-01 | 0.933 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.176201e-01 | 0.930 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.185673e-01 | 0.926 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.240669e-01 | 0.906 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.240675e-01 | 0.906 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.240675e-01 | 0.906 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.240675e-01 | 0.906 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.263913e-01 | 0.898 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.265064e-01 | 0.898 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.265064e-01 | 0.898 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.265243e-01 | 0.898 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.265243e-01 | 0.898 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.265243e-01 | 0.898 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.265243e-01 | 0.898 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.265243e-01 | 0.898 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.265981e-01 | 0.898 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.265981e-01 | 0.898 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.265981e-01 | 0.898 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.265981e-01 | 0.898 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.265981e-01 | 0.898 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.265981e-01 | 0.898 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.265981e-01 | 0.898 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.851042e-01 | 0.733 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.851042e-01 | 0.733 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.851042e-01 | 0.733 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.851042e-01 | 0.733 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.851042e-01 | 0.733 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.851042e-01 | 0.733 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.614996e-01 | 0.792 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 1.614996e-01 | 0.792 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.614996e-01 | 0.792 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.614996e-01 | 0.792 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 1.614996e-01 | 0.792 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.979393e-01 | 0.703 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.979393e-01 | 0.703 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.498896e-01 | 0.824 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.352279e-01 | 0.629 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.352279e-01 | 0.629 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.744172e-01 | 0.758 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.744172e-01 | 0.758 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.744172e-01 | 0.758 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.744172e-01 | 0.758 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.744172e-01 | 0.758 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.328909e-01 | 0.877 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.328909e-01 | 0.877 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.328909e-01 | 0.877 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.328909e-01 | 0.877 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.513137e-01 | 0.820 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.706387e-01 | 0.768 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.263186e-01 | 0.645 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.263186e-01 | 0.645 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.263186e-01 | 0.645 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.263186e-01 | 0.645 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.263186e-01 | 0.645 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.263186e-01 | 0.645 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.263186e-01 | 0.645 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.263186e-01 | 0.645 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.907658e-01 | 0.719 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.907658e-01 | 0.719 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.532816e-01 | 0.596 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.532816e-01 | 0.596 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.115923e-01 | 0.675 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.115923e-01 | 0.675 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.330149e-01 | 0.633 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.143794e-01 | 0.669 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.455606e-01 | 0.837 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.549312e-01 | 0.594 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.549312e-01 | 0.594 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.549312e-01 | 0.594 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.549312e-01 | 0.594 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.549312e-01 | 0.594 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.549312e-01 | 0.594 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.514827e-01 | 0.599 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.672262e-01 | 0.777 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.784490e-01 | 0.748 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 2.460347e-01 | 0.609 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.140345e-01 | 0.670 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.143794e-01 | 0.669 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.143794e-01 | 0.669 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.824208e-01 | 0.739 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.327198e-01 | 0.633 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.327198e-01 | 0.633 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.133214e-01 | 0.671 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.115923e-01 | 0.675 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.975659e-01 | 0.704 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.497992e-01 | 0.824 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.532816e-01 | 0.596 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.328909e-01 | 0.877 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.243847e-01 | 0.649 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.614996e-01 | 0.792 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.498896e-01 | 0.824 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.706387e-01 | 0.768 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.394914e-01 | 0.855 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.514827e-01 | 0.599 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.706387e-01 | 0.768 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.327198e-01 | 0.633 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.734596e-01 | 0.761 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.999636e-01 | 0.699 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.327198e-01 | 0.633 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.644603e-01 | 0.784 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.975659e-01 | 0.704 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.979393e-01 | 0.703 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.706387e-01 | 0.768 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.455606e-01 | 0.837 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.196134e-01 | 0.658 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.249536e-01 | 0.648 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.934804e-01 | 0.713 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.625160e-01 | 0.789 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.569486e-01 | 0.804 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.970449e-01 | 0.705 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.455606e-01 | 0.837 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.143794e-01 | 0.669 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.320758e-01 | 0.879 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.352279e-01 | 0.629 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.311664e-01 | 0.882 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.328909e-01 | 0.877 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.464811e-01 | 0.834 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.558842e-01 | 0.592 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.445956e-01 | 0.612 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.756954e-01 | 0.755 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.460347e-01 | 0.609 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.325573e-01 | 0.878 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.230120e-01 | 0.652 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.851042e-01 | 0.733 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.851042e-01 | 0.733 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.614996e-01 | 0.792 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.979393e-01 | 0.703 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.352279e-01 | 0.629 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.513137e-01 | 0.820 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.513137e-01 | 0.820 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.513137e-01 | 0.820 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.999636e-01 | 0.699 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.999636e-01 | 0.699 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.907658e-01 | 0.719 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.532816e-01 | 0.596 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.531929e-01 | 0.815 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.531929e-01 | 0.815 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.318152e-01 | 0.880 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.809270e-01 | 0.742 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.635999e-01 | 0.786 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.140345e-01 | 0.670 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.906816e-01 | 0.720 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.394914e-01 | 0.855 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.103561e-01 | 0.677 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 1.649578e-01 | 0.783 | 1 | 1 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.416494e-01 | 0.849 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.437464e-01 | 0.842 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.921575e-01 | 0.716 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.575054e-01 | 0.589 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.330149e-01 | 0.633 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.143794e-01 | 0.669 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.753693e-01 | 0.756 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.936227e-01 | 0.713 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.975659e-01 | 0.704 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.115923e-01 | 0.675 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.103561e-01 | 0.677 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 1.614996e-01 | 0.792 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.979393e-01 | 0.703 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.352279e-01 | 0.629 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.822666e-01 | 0.739 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.563478e-01 | 0.806 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.294917e-01 | 0.639 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.445956e-01 | 0.612 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 2.359846e-01 | 0.627 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.464811e-01 | 0.834 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 1.965243e-01 | 0.707 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.776082e-01 | 0.751 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.311664e-01 | 0.882 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.311664e-01 | 0.882 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.776082e-01 | 0.751 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.979393e-01 | 0.703 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.355813e-01 | 0.628 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.425141e-01 | 0.615 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.138490e-01 | 0.670 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.498896e-01 | 0.824 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.115923e-01 | 0.675 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.115923e-01 | 0.675 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.327198e-01 | 0.633 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.330149e-01 | 0.633 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.513137e-01 | 0.820 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 2.532816e-01 | 0.596 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 2.585819e-01 | 0.587 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.397513e-01 | 0.620 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.629074e-01 | 0.580 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.643878e-01 | 0.578 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 2.643878e-01 | 0.578 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.643878e-01 | 0.578 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 2.643878e-01 | 0.578 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.643878e-01 | 0.578 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 2.643878e-01 | 0.578 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.643878e-01 | 0.578 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.643878e-01 | 0.578 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.643878e-01 | 0.578 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.643878e-01 | 0.578 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.643878e-01 | 0.578 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.643878e-01 | 0.578 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.643878e-01 | 0.578 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.643878e-01 | 0.578 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.643878e-01 | 0.578 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.643878e-01 | 0.578 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.643878e-01 | 0.578 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.703614e-01 | 0.568 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.706053e-01 | 0.568 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.728557e-01 | 0.564 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.728557e-01 | 0.564 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.728557e-01 | 0.564 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.728557e-01 | 0.564 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.728557e-01 | 0.564 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.728557e-01 | 0.564 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.728557e-01 | 0.564 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.730118e-01 | 0.564 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.730118e-01 | 0.564 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.753495e-01 | 0.560 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.753495e-01 | 0.560 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.787014e-01 | 0.555 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.787014e-01 | 0.555 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.806643e-01 | 0.552 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.809142e-01 | 0.551 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.830838e-01 | 0.548 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.860424e-01 | 0.544 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.860424e-01 | 0.544 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.860424e-01 | 0.544 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.860424e-01 | 0.544 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.900249e-01 | 0.538 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.900249e-01 | 0.538 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.900249e-01 | 0.538 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.922687e-01 | 0.534 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.938978e-01 | 0.532 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.960499e-01 | 0.529 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.998451e-01 | 0.523 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.998451e-01 | 0.523 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.998451e-01 | 0.523 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.998451e-01 | 0.523 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.019311e-01 | 0.520 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.019311e-01 | 0.520 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.060005e-01 | 0.514 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.062378e-01 | 0.514 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.082916e-01 | 0.511 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.096798e-01 | 0.509 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.096798e-01 | 0.509 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.096798e-01 | 0.509 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.096798e-01 | 0.509 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.104042e-01 | 0.508 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.104042e-01 | 0.508 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.104042e-01 | 0.508 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.198765e-01 | 0.495 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.226511e-01 | 0.491 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.226511e-01 | 0.491 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.280802e-01 | 0.484 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.280802e-01 | 0.484 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.280802e-01 | 0.484 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.295097e-01 | 0.482 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.328264e-01 | 0.478 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.328447e-01 | 0.478 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.342020e-01 | 0.476 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.342020e-01 | 0.476 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.359618e-01 | 0.474 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.359618e-01 | 0.474 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.359618e-01 | 0.474 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.359618e-01 | 0.474 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.359618e-01 | 0.474 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.359618e-01 | 0.474 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.359618e-01 | 0.474 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.359618e-01 | 0.474 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.359618e-01 | 0.474 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.359618e-01 | 0.474 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.359618e-01 | 0.474 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.360029e-01 | 0.474 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.360029e-01 | 0.474 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.360029e-01 | 0.474 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.360029e-01 | 0.474 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.360029e-01 | 0.474 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.360029e-01 | 0.474 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.396994e-01 | 0.469 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.455689e-01 | 0.461 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.455689e-01 | 0.461 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.461184e-01 | 0.461 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.475328e-01 | 0.459 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.475328e-01 | 0.459 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.475328e-01 | 0.459 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 3.475328e-01 | 0.459 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.475328e-01 | 0.459 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.475328e-01 | 0.459 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.475328e-01 | 0.459 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.475328e-01 | 0.459 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.475328e-01 | 0.459 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.475328e-01 | 0.459 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.481473e-01 | 0.458 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.481473e-01 | 0.458 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.494561e-01 | 0.457 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.494561e-01 | 0.457 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.505202e-01 | 0.455 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.505202e-01 | 0.455 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.505202e-01 | 0.455 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.538545e-01 | 0.451 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.592379e-01 | 0.445 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.631042e-01 | 0.440 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.631042e-01 | 0.440 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.631042e-01 | 0.440 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.636522e-01 | 0.439 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.636522e-01 | 0.439 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.636522e-01 | 0.439 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.636522e-01 | 0.439 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.646869e-01 | 0.438 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.685141e-01 | 0.434 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.685141e-01 | 0.434 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.685141e-01 | 0.434 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.685141e-01 | 0.434 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.686452e-01 | 0.433 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.694624e-01 | 0.432 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.694624e-01 | 0.432 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.694624e-01 | 0.432 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.694624e-01 | 0.432 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.774647e-01 | 0.423 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.839680e-01 | 0.416 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.839680e-01 | 0.416 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.839680e-01 | 0.416 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.839680e-01 | 0.416 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.839680e-01 | 0.416 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.839680e-01 | 0.416 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.839680e-01 | 0.416 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.839680e-01 | 0.416 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.839680e-01 | 0.416 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.894746e-01 | 0.410 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.903206e-01 | 0.409 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.911083e-01 | 0.408 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.911083e-01 | 0.408 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.911083e-01 | 0.408 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.914074e-01 | 0.407 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.925009e-01 | 0.406 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.928182e-01 | 0.406 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 3.949805e-01 | 0.403 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.000043e-01 | 0.398 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.005756e-01 | 0.397 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.005756e-01 | 0.397 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.005756e-01 | 0.397 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.005756e-01 | 0.397 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.005756e-01 | 0.397 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.005756e-01 | 0.397 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 4.005756e-01 | 0.397 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.005756e-01 | 0.397 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.005756e-01 | 0.397 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.005756e-01 | 0.397 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.005756e-01 | 0.397 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.005756e-01 | 0.397 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.040824e-01 | 0.394 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.094415e-01 | 0.388 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.094415e-01 | 0.388 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.104746e-01 | 0.387 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.133873e-01 | 0.384 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.141752e-01 | 0.383 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.141752e-01 | 0.383 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.182545e-01 | 0.379 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.182545e-01 | 0.379 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.182545e-01 | 0.379 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.182545e-01 | 0.379 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.194934e-01 | 0.377 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.194934e-01 | 0.377 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.194934e-01 | 0.377 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.194934e-01 | 0.377 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.194934e-01 | 0.377 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.194934e-01 | 0.377 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.194934e-01 | 0.377 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.225372e-01 | 0.374 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.293142e-01 | 0.367 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.367496e-01 | 0.360 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.367496e-01 | 0.360 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.367496e-01 | 0.360 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.367496e-01 | 0.360 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.367496e-01 | 0.360 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.393151e-01 | 0.357 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.393151e-01 | 0.357 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.403966e-01 | 0.356 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.449883e-01 | 0.352 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.449883e-01 | 0.352 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 4.449883e-01 | 0.352 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.479138e-01 | 0.349 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.490474e-01 | 0.348 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.490474e-01 | 0.348 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.538801e-01 | 0.343 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.539412e-01 | 0.343 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.539412e-01 | 0.343 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.539412e-01 | 0.343 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.539412e-01 | 0.343 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.539412e-01 | 0.343 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.539412e-01 | 0.343 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.539412e-01 | 0.343 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.539412e-01 | 0.343 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.562501e-01 | 0.341 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.575005e-01 | 0.340 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.581196e-01 | 0.339 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.581466e-01 | 0.339 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.581466e-01 | 0.339 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.581466e-01 | 0.339 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.581466e-01 | 0.339 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.589056e-01 | 0.338 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.589056e-01 | 0.338 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.589056e-01 | 0.338 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.589056e-01 | 0.338 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.589056e-01 | 0.338 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.589056e-01 | 0.338 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.589056e-01 | 0.338 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.589056e-01 | 0.338 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.589056e-01 | 0.338 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.589056e-01 | 0.338 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.589056e-01 | 0.338 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.589056e-01 | 0.338 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.590686e-01 | 0.338 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.590686e-01 | 0.338 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.590686e-01 | 0.338 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.590686e-01 | 0.338 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.712203e-01 | 0.327 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.712203e-01 | 0.327 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.712203e-01 | 0.327 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.718593e-01 | 0.326 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.718593e-01 | 0.326 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.757560e-01 | 0.323 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.757560e-01 | 0.323 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.757560e-01 | 0.323 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.800305e-01 | 0.319 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.810761e-01 | 0.318 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.860579e-01 | 0.313 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.871848e-01 | 0.312 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.871848e-01 | 0.312 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.871848e-01 | 0.312 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.871848e-01 | 0.312 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.871848e-01 | 0.312 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.871848e-01 | 0.312 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.879282e-01 | 0.312 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.879282e-01 | 0.312 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.931951e-01 | 0.307 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.939649e-01 | 0.306 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.940146e-01 | 0.306 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.941315e-01 | 0.306 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.941315e-01 | 0.306 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 4.968256e-01 | 0.304 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 4.968742e-01 | 0.304 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.968742e-01 | 0.304 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.968742e-01 | 0.304 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.027216e-01 | 0.299 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.027216e-01 | 0.299 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.066460e-01 | 0.295 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 5.070002e-01 | 0.295 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 5.070002e-01 | 0.295 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.070002e-01 | 0.295 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.070002e-01 | 0.295 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.071702e-01 | 0.295 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.104365e-01 | 0.292 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.115626e-01 | 0.291 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.115626e-01 | 0.291 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.115626e-01 | 0.291 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.115626e-01 | 0.291 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.115626e-01 | 0.291 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.115626e-01 | 0.291 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 5.115626e-01 | 0.291 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.115626e-01 | 0.291 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.115626e-01 | 0.291 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.115626e-01 | 0.291 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.115626e-01 | 0.291 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.178512e-01 | 0.286 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.191324e-01 | 0.285 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.191324e-01 | 0.285 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.191324e-01 | 0.285 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.191324e-01 | 0.285 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.191324e-01 | 0.285 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.191324e-01 | 0.285 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.191324e-01 | 0.285 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.217207e-01 | 0.283 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.218854e-01 | 0.282 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.239603e-01 | 0.281 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.257816e-01 | 0.279 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.257816e-01 | 0.279 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.257816e-01 | 0.279 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.257816e-01 | 0.279 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.272945e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.272945e-01 | 0.278 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.274547e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.316610e-01 | 0.274 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.330001e-01 | 0.273 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.331344e-01 | 0.273 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.442424e-01 | 0.264 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.462005e-01 | 0.263 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.497214e-01 | 0.260 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.497214e-01 | 0.260 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.497214e-01 | 0.260 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.497214e-01 | 0.260 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.497214e-01 | 0.260 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.497214e-01 | 0.260 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.590981e-01 | 0.253 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.590981e-01 | 0.253 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.590981e-01 | 0.253 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.590981e-01 | 0.253 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.590981e-01 | 0.253 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.590981e-01 | 0.253 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.590981e-01 | 0.253 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.590981e-01 | 0.253 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 5.590981e-01 | 0.253 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.590981e-01 | 0.253 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.590981e-01 | 0.253 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.590981e-01 | 0.253 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.590981e-01 | 0.253 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.590981e-01 | 0.253 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.590981e-01 | 0.253 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.590981e-01 | 0.253 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.590981e-01 | 0.253 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.590981e-01 | 0.253 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.590981e-01 | 0.253 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.594451e-01 | 0.252 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.650649e-01 | 0.248 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.650649e-01 | 0.248 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.650649e-01 | 0.248 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.697761e-01 | 0.244 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.697761e-01 | 0.244 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.732656e-01 | 0.242 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.769448e-01 | 0.239 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.789138e-01 | 0.237 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.789138e-01 | 0.237 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.789138e-01 | 0.237 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.789138e-01 | 0.237 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.789138e-01 | 0.237 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.848674e-01 | 0.233 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 5.848674e-01 | 0.233 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.928548e-01 | 0.227 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.020099e-01 | 0.220 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.020099e-01 | 0.220 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.020099e-01 | 0.220 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.020099e-01 | 0.220 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.020099e-01 | 0.220 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.020099e-01 | 0.220 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.020099e-01 | 0.220 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.020099e-01 | 0.220 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.020099e-01 | 0.220 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.020099e-01 | 0.220 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.020099e-01 | 0.220 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.041360e-01 | 0.219 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.066915e-01 | 0.217 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.066915e-01 | 0.217 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.066915e-01 | 0.217 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.066915e-01 | 0.217 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.106846e-01 | 0.214 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.145817e-01 | 0.211 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.145817e-01 | 0.211 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.145817e-01 | 0.211 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.145817e-01 | 0.211 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.284518e-01 | 0.202 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.330535e-01 | 0.199 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.330535e-01 | 0.199 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.357686e-01 | 0.197 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.386055e-01 | 0.195 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.407475e-01 | 0.193 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.407475e-01 | 0.193 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 6.407475e-01 | 0.193 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.407475e-01 | 0.193 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.407475e-01 | 0.193 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.407475e-01 | 0.193 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.407475e-01 | 0.193 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.407475e-01 | 0.193 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.407475e-01 | 0.193 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.407475e-01 | 0.193 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.407475e-01 | 0.193 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.407475e-01 | 0.193 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.407475e-01 | 0.193 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.407475e-01 | 0.193 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.407475e-01 | 0.193 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.407475e-01 | 0.193 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.407475e-01 | 0.193 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.409955e-01 | 0.193 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.409955e-01 | 0.193 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.409955e-01 | 0.193 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.449351e-01 | 0.190 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.459377e-01 | 0.190 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.490804e-01 | 0.188 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.561279e-01 | 0.183 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.566196e-01 | 0.183 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.580122e-01 | 0.182 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.580122e-01 | 0.182 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.580122e-01 | 0.182 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.580122e-01 | 0.182 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.592993e-01 | 0.181 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.755314e-01 | 0.170 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.755314e-01 | 0.170 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.756549e-01 | 0.170 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.757167e-01 | 0.170 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.757167e-01 | 0.170 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.757167e-01 | 0.170 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.757167e-01 | 0.170 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.757167e-01 | 0.170 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.757167e-01 | 0.170 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.757167e-01 | 0.170 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.757167e-01 | 0.170 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.757167e-01 | 0.170 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.757167e-01 | 0.170 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.757167e-01 | 0.170 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.777814e-01 | 0.169 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.811524e-01 | 0.167 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.811524e-01 | 0.167 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.815909e-01 | 0.166 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.815909e-01 | 0.166 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.815909e-01 | 0.166 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.815909e-01 | 0.166 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.815909e-01 | 0.166 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.850843e-01 | 0.164 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 6.854160e-01 | 0.164 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.919090e-01 | 0.160 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.919090e-01 | 0.160 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.943500e-01 | 0.158 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.038218e-01 | 0.153 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.038218e-01 | 0.153 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.038218e-01 | 0.153 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.038218e-01 | 0.153 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.067341e-01 | 0.151 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.072839e-01 | 0.150 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.072839e-01 | 0.150 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.072839e-01 | 0.150 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.072839e-01 | 0.150 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.072839e-01 | 0.150 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.072839e-01 | 0.150 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.072839e-01 | 0.150 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.072839e-01 | 0.150 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.072839e-01 | 0.150 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.072839e-01 | 0.150 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.072839e-01 | 0.150 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.072839e-01 | 0.150 | 0 | 0 |
| Expression of NOTCH2NL genes | R-HSA-9911233 | 7.072839e-01 | 0.150 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.072839e-01 | 0.150 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.072839e-01 | 0.150 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.072839e-01 | 0.150 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.076378e-01 | 0.150 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.076892e-01 | 0.150 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.076892e-01 | 0.150 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.076892e-01 | 0.150 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.076892e-01 | 0.150 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.083303e-01 | 0.150 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.122186e-01 | 0.147 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.122186e-01 | 0.147 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.151602e-01 | 0.146 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.183748e-01 | 0.144 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.199735e-01 | 0.143 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.203044e-01 | 0.142 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.247438e-01 | 0.140 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.247438e-01 | 0.140 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.247438e-01 | 0.140 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.247438e-01 | 0.140 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.247438e-01 | 0.140 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.356530e-01 | 0.133 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.357799e-01 | 0.133 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.357799e-01 | 0.133 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.357799e-01 | 0.133 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.357799e-01 | 0.133 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.357799e-01 | 0.133 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.357799e-01 | 0.133 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.357799e-01 | 0.133 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.357799e-01 | 0.133 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.374624e-01 | 0.132 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.444010e-01 | 0.128 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.444010e-01 | 0.128 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.444010e-01 | 0.128 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.444010e-01 | 0.128 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.455169e-01 | 0.128 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.459221e-01 | 0.127 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.471442e-01 | 0.127 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.512005e-01 | 0.124 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.609753e-01 | 0.119 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.609753e-01 | 0.119 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.615033e-01 | 0.118 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.615033e-01 | 0.118 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.615033e-01 | 0.118 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.615033e-01 | 0.118 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.615033e-01 | 0.118 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.615033e-01 | 0.118 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.628413e-01 | 0.118 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.628413e-01 | 0.118 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.628413e-01 | 0.118 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.709446e-01 | 0.113 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.709446e-01 | 0.113 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.756634e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.756634e-01 | 0.110 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.756634e-01 | 0.110 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.801153e-01 | 0.108 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.801153e-01 | 0.108 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.801153e-01 | 0.108 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.801153e-01 | 0.108 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.801153e-01 | 0.108 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.801153e-01 | 0.108 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.801153e-01 | 0.108 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.847237e-01 | 0.105 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.847237e-01 | 0.105 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.847237e-01 | 0.105 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.847237e-01 | 0.105 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.847237e-01 | 0.105 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.847237e-01 | 0.105 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.847237e-01 | 0.105 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.896018e-01 | 0.103 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.934155e-01 | 0.100 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.962753e-01 | 0.099 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.962753e-01 | 0.099 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.962753e-01 | 0.099 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.962753e-01 | 0.099 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.962753e-01 | 0.099 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.984360e-01 | 0.098 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.007682e-01 | 0.096 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 8.017522e-01 | 0.096 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.017522e-01 | 0.096 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.017522e-01 | 0.096 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.028123e-01 | 0.095 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.056846e-01 | 0.094 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.056846e-01 | 0.094 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.056846e-01 | 0.094 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.056846e-01 | 0.094 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.056846e-01 | 0.094 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.056846e-01 | 0.094 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.056846e-01 | 0.094 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.056846e-01 | 0.094 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.056846e-01 | 0.094 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.056846e-01 | 0.094 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.064269e-01 | 0.093 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.113744e-01 | 0.091 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.113744e-01 | 0.091 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.141221e-01 | 0.089 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.153185e-01 | 0.089 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.153185e-01 | 0.089 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.205809e-01 | 0.086 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.232060e-01 | 0.084 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.238346e-01 | 0.084 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.246058e-01 | 0.084 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.246058e-01 | 0.084 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.246058e-01 | 0.084 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.246058e-01 | 0.084 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.246058e-01 | 0.084 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.246058e-01 | 0.084 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.246058e-01 | 0.084 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.254659e-01 | 0.083 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.254659e-01 | 0.083 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.254659e-01 | 0.083 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.260012e-01 | 0.083 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.268204e-01 | 0.083 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.271447e-01 | 0.082 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.331220e-01 | 0.079 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.331325e-01 | 0.079 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.331325e-01 | 0.079 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.386028e-01 | 0.076 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.386028e-01 | 0.076 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.386028e-01 | 0.076 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.386028e-01 | 0.076 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.386028e-01 | 0.076 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.416855e-01 | 0.075 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.416855e-01 | 0.075 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 8.416855e-01 | 0.075 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.416855e-01 | 0.075 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 8.416855e-01 | 0.075 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.416855e-01 | 0.075 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 8.416855e-01 | 0.075 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.416855e-01 | 0.075 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.416855e-01 | 0.075 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.416855e-01 | 0.075 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.420257e-01 | 0.075 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.420257e-01 | 0.075 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.488579e-01 | 0.071 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.506549e-01 | 0.070 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.508374e-01 | 0.070 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.508374e-01 | 0.070 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.508374e-01 | 0.070 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.508374e-01 | 0.070 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.508374e-01 | 0.070 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.508621e-01 | 0.070 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.521346e-01 | 0.069 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.571029e-01 | 0.067 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.571029e-01 | 0.067 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.571029e-01 | 0.067 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.571029e-01 | 0.067 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.571029e-01 | 0.067 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.571029e-01 | 0.067 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.586407e-01 | 0.066 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.586407e-01 | 0.066 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.587962e-01 | 0.066 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.587962e-01 | 0.066 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.617236e-01 | 0.065 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.622208e-01 | 0.064 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.622208e-01 | 0.064 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.622208e-01 | 0.064 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.626072e-01 | 0.064 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.654476e-01 | 0.063 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.663845e-01 | 0.062 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.681568e-01 | 0.061 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.681568e-01 | 0.061 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.696687e-01 | 0.061 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 8.710197e-01 | 0.060 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.710197e-01 | 0.060 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.710197e-01 | 0.060 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.710197e-01 | 0.060 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.710197e-01 | 0.060 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.720799e-01 | 0.059 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.728026e-01 | 0.059 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.728026e-01 | 0.059 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.728026e-01 | 0.059 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.728026e-01 | 0.059 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.728026e-01 | 0.059 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 8.728026e-01 | 0.059 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.769653e-01 | 0.057 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.769653e-01 | 0.057 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.769653e-01 | 0.057 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.769653e-01 | 0.057 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.775261e-01 | 0.057 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.775261e-01 | 0.057 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.775261e-01 | 0.057 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.826311e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.826311e-01 | 0.054 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.826311e-01 | 0.054 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.826311e-01 | 0.054 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.835819e-01 | 0.054 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.835819e-01 | 0.054 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.835819e-01 | 0.054 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.835819e-01 | 0.054 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.835819e-01 | 0.054 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.835819e-01 | 0.054 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.835819e-01 | 0.054 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.835819e-01 | 0.054 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.888803e-01 | 0.051 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.896325e-01 | 0.051 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.904353e-01 | 0.050 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.917525e-01 | 0.050 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.930276e-01 | 0.049 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.949213e-01 | 0.048 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.949213e-01 | 0.048 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.949213e-01 | 0.048 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.949213e-01 | 0.048 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.949213e-01 | 0.048 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.002113e-01 | 0.046 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.003311e-01 | 0.046 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.049666e-01 | 0.043 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.051567e-01 | 0.043 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.051567e-01 | 0.043 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.051567e-01 | 0.043 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.051567e-01 | 0.043 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.051567e-01 | 0.043 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.051567e-01 | 0.043 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.051567e-01 | 0.043 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.064488e-01 | 0.043 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.071817e-01 | 0.042 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.080500e-01 | 0.042 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.080500e-01 | 0.042 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.109147e-01 | 0.041 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.109147e-01 | 0.041 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.109147e-01 | 0.041 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.123421e-01 | 0.040 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.123421e-01 | 0.040 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.136027e-01 | 0.039 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.143958e-01 | 0.039 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.143958e-01 | 0.039 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.143958e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.143958e-01 | 0.039 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.143958e-01 | 0.039 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.143958e-01 | 0.039 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.143958e-01 | 0.039 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.143958e-01 | 0.039 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.153090e-01 | 0.038 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.153090e-01 | 0.038 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.163257e-01 | 0.038 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.182951e-01 | 0.037 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.196170e-01 | 0.036 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.212408e-01 | 0.036 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.220270e-01 | 0.035 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.220270e-01 | 0.035 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.220270e-01 | 0.035 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.222605e-01 | 0.035 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.224100e-01 | 0.035 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.227353e-01 | 0.035 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.227353e-01 | 0.035 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.227353e-01 | 0.035 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.252463e-01 | 0.034 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.268171e-01 | 0.033 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.282404e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.282404e-01 | 0.032 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.282404e-01 | 0.032 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.282404e-01 | 0.032 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.302628e-01 | 0.031 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.302628e-01 | 0.031 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.302628e-01 | 0.031 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.302628e-01 | 0.031 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.302628e-01 | 0.031 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.302628e-01 | 0.031 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.302628e-01 | 0.031 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.302628e-01 | 0.031 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.315201e-01 | 0.031 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.324437e-01 | 0.030 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.339837e-01 | 0.030 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.339837e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.354342e-01 | 0.029 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.354342e-01 | 0.029 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.370573e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.370573e-01 | 0.028 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.370573e-01 | 0.028 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.370573e-01 | 0.028 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.370573e-01 | 0.028 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.370573e-01 | 0.028 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.392896e-01 | 0.027 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.392896e-01 | 0.027 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.392896e-01 | 0.027 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.400328e-01 | 0.027 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.431902e-01 | 0.025 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.431902e-01 | 0.025 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.431902e-01 | 0.025 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.431902e-01 | 0.025 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.431902e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.441887e-01 | 0.025 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.443263e-01 | 0.025 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.443263e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.477146e-01 | 0.023 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.477146e-01 | 0.023 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.483328e-01 | 0.023 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.487098e-01 | 0.023 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.487259e-01 | 0.023 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.487259e-01 | 0.023 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.487259e-01 | 0.023 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.487259e-01 | 0.023 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.487259e-01 | 0.023 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.487259e-01 | 0.023 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.528802e-01 | 0.021 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.537225e-01 | 0.021 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.537225e-01 | 0.021 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.537225e-01 | 0.021 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.537225e-01 | 0.021 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.537225e-01 | 0.021 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.537225e-01 | 0.021 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.537225e-01 | 0.021 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.541617e-01 | 0.020 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.574685e-01 | 0.019 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.582324e-01 | 0.019 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.582324e-01 | 0.019 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.582324e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.582324e-01 | 0.019 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.582324e-01 | 0.019 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.582324e-01 | 0.019 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.582324e-01 | 0.019 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.582324e-01 | 0.019 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.602685e-01 | 0.018 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.603266e-01 | 0.018 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.623030e-01 | 0.017 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.623030e-01 | 0.017 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.635326e-01 | 0.016 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.635326e-01 | 0.016 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.646308e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.659772e-01 | 0.015 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.678672e-01 | 0.014 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.692934e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.692934e-01 | 0.014 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.692934e-01 | 0.014 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.693043e-01 | 0.014 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.700680e-01 | 0.013 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.722866e-01 | 0.012 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.722866e-01 | 0.012 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.726256e-01 | 0.012 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.749882e-01 | 0.011 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.755578e-01 | 0.011 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.758539e-01 | 0.011 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.774265e-01 | 0.010 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.774265e-01 | 0.010 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.774265e-01 | 0.010 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.775365e-01 | 0.010 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.778024e-01 | 0.010 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.797568e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.800073e-01 | 0.009 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.808981e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.810940e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.815342e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.816137e-01 | 0.008 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.832238e-01 | 0.007 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.833397e-01 | 0.007 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.834064e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.838166e-01 | 0.007 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.846252e-01 | 0.007 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.846252e-01 | 0.007 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.850245e-01 | 0.007 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.850245e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.850245e-01 | 0.007 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.850245e-01 | 0.007 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.851077e-01 | 0.007 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.863062e-01 | 0.006 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.870864e-01 | 0.006 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.873571e-01 | 0.006 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.873571e-01 | 0.006 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.878029e-01 | 0.005 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.889925e-01 | 0.005 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.889925e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.900661e-01 | 0.004 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.902172e-01 | 0.004 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.907671e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.910350e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.919095e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.919095e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.919095e-01 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.925229e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.926988e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.927998e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.933680e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.934111e-01 | 0.003 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.934111e-01 | 0.003 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.937549e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.938944e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.940539e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.940539e-01 | 0.003 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.942939e-01 | 0.002 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.943771e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.951576e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.951576e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.956518e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.957186e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.963750e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.966348e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.970495e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.970775e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.971022e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.972437e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.974990e-01 | 0.001 | 1 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.975653e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.977053e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.978377e-01 | 0.001 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.980906e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.984716e-01 | 0.001 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.985520e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.986992e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.987261e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.987691e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.989799e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.990494e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.990640e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.990640e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.990640e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.991332e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.991555e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.992039e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.992784e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.993331e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.993388e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.993538e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.993705e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.996979e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996979e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997034e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.997629e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997698e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998199e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998674e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998920e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999545e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999555e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999768e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999829e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999830e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999831e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999862e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999910e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999918e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999930e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999933e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999947e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999956e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999956e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999960e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999984e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999988e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999992e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999992e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999993e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999994e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999995e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999998e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |